Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3041423	s-ssa-60	— (—)	3182	3829	100.00%	Distribution not available
3041423	s-sjögreninsyndroma,a(ro60)-vasta-aineet	— (—)	929	1001	100.00%	Distribution not available
3041423	s-ssa-60	U/ml (u/ml)	145	201	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

289

26.93

321.53

1.3

1.1

65.91

—

u/ml

—

Autoimmune diseases related-to ILD

1116

2625

3.60

314.68

1.4

1.2

79.05

51.98

u/ml

1.87

ILD medications: immunosuppressive drugs

1131

1678

6.25

307.65

1.3

1.2

72.78

57.04

u/ml

0.62

Systemic connective tissue disorders

1014

1209

8.83

307.65

1.5

1.1

79.37

58.75

u/ml

0.74

Other systemic involvement of connective tissue

762

933

8.59

307.65

1.5

1.1

89.77

68.68

u/ml

0.60

Other specific joint derangements/joint disorders

1000

1304

4.86

307.65

1.3

1.2

64.52

68.00

u/ml

0.09

Inflammatory bowel disease treatment related agents

1477

2183

3.81

307.65

1.3

1.2

77.03

59.12

u/ml

0.91

ILD medications: prednisolone, methylprednisolone, prednisone

1415

1795

4.45

307.65

1.3

1.2

79.98

57.04

u/ml

1.18

Finngen Rheumatological endpoints

1156

1585

4.20

307.65

1.3

1.1

62.87

54.96

u/ml

0.23

Oral corticosteroids

1448

2150

4.01

307.65

1.3

1.2

80.55

59.89

u/ml

1.14

Reimbursement for rheumatic diseases

979

2189

4.55

307.65

1.4

1.2

78.22

66.18

u/ml

0.51

ILD medications

1514

1807

4.58

307.65

1.3

1.2

72.03

57.04

u/ml

0.66

Polyarthropathies

936

1212

5.05

307.65

1.3

1.2

87.55

71.76

u/ml

0.47

L04AX Other immunosuppressants

924

2186

4.32

307.65

1.3

1.2

82.41

65.76

u/ml

0.62

Other systemic involvement of connective tissue (FG)

757

647

12.10

307.65

1.5

1.1

89.77

83.85

u/ml

0.13

Second line medication for Crohn's disease

949

2254

4.30

307.65

1.3

1.2

80.58

65.16

u/ml

0.57

First line medication for Crohn's disease

1267

1939

3.56

302.46

1.3

1.2

77.54

56.46

u/ml

0.97

Pain in joint

825

1110

4.64

289.16

1.3

1.2

71.96

62.16

u/ml

0.25

Autoimmune diseases excluding thyroid diseases

1213

1899

3.50

284.35

1.3

1.2

74.75

63.50

u/ml

0.36

Autoimmune diseases excluding thyroid diseases, strict definition

1189

1847

3.54

283.64

1.3

1.2

77.17

63.92

u/ml

0.42

ILD, hospital admissions

367

474

8.13

267.47

1.3

1.2

78.08

78.95

u/ml

0.01

Interstitial lung disease

368

480

8.04

265.90

1.3

1.2

78.08

76.80

u/ml

0.02

Interstitial lung disease endpoints

368

480

8.04

265.90

1.3

1.2

78.08

76.80

u/ml

0.02

Other interstitial pulmonary diseases

368

481

8.02

265.43

1.3

1.2

78.08

76.80

u/ml

0.02

Rheumatoid arthritis

494

773

5.79

253.64

1.3

1.2

99.04

75.44

u/ml

0.71

Other respiratory diseases principally affecting the interstitium

381

563

7.04

245.81

1.3

1.1

78.08

73.29

u/ml

0.07

ILD, hospital admissions 1, main diag only

333

426

8.22

244.80

1.3

1.1

79.40

78.44

u/ml

—

Medical observation and evaluation for suspected diseases and conditions

716

821

4.51

224.98

1.3

1.2

87.87

61.57

u/ml

0.87

Other arthritis (FG)

433

797

5.55

222.75

1.3

1.1

58.46

81.38

u/ml

0.43

Other and unspecified dermatitis

739

2091

3.60

218.36

1.3

1.2

62.25

70.10

u/ml

0.30

Dermatitis

834

2491

3.33

217.13

1.3

1.2

58.88

74.28

u/ml

0.76

Raynaud syndrome

266

305

9.28

214.32

1.5

1.2

69.11

48.60

u/ml

—

Other peripheral vascular diseases

247

269

9.78

207.09

1.5

1.2

69.75

49.56

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

842

2302

3.23

203.04

1.3

1.2

70.25

74.37

u/ml

0.12

Abnormal findings on diagnostic imaging of lung

672

1759

3.69

202.88

1.2

72.29

88.79

u/ml

0.57

Other specified/unspecified arthritis

377

726

5.30

184.58

1.3

1.2

63.25

80.18

u/ml

0.32

Gastro-oesophageal reflux disease

841

2361

3.04

182.55

1.2

65.50

72.89

u/ml

0.21

Dermatitis and eczema

1208

2754

2.62

181.44

1.3

1.2

62.10

72.48

u/ml

0.47

Other joint disorders

836

1319

3.34

180.72

1.3

1.2

82.76

68.00

u/ml

0.40

Autoimmune diseases

1069

1910

2.87

179.74

1.3

1.2

61.60

63.50

u/ml

0.05

Polyarthrosis

320

496

5.96

170.22

1.2

57.21

80.28

u/ml

0.66

Systemic lupus erythematosus

145

17.04

169.79

1.8

1.1

59.93

—

u/ml

—

Other soft tissue disorders, not elsewhere classified

962

1933

2.86

167.32

1.3

1.2

86.39

57.20

u/ml

1.57

Rheumatoid arthritis, including avohilmo

547

1533

3.64

164.48

1.3

1.2

96.07

71.16

u/ml

0.89

Seropositive rheumatoid arthritis

328

622

5.36

162.12

1.2

1.1

104.04

80.80

u/ml

—

Chronic laryngitis and laryngotracheitis

280

484

6.00

154.85

1.3

1.2

106.43

58.60

u/ml

—

Used for control exclusion in common control thyroid runs

950

1757

2.75

148.36

1.3

1.2

62.12

66.22

u/ml

0.10

Other disorders of skin and subcutaneous tissue, not elsewhere classified

272

485

5.80

145.55

1.3

1.2

84.28

68.23

u/ml

0.26

Arthropathies

785

1320

3.03

144.89

1.3

1.2

73.00

66.76

u/ml

0.16

Other and unspecified disorders of skin and subcutaneous tissue

177

199

9.45

144.88

1.3

1.2

73.80

67.29

u/ml

—

Myalgia

357

808

4.51

144.29

1.4

1.2

75.89

62.67

u/ml

0.35

Polymyalgia rheumatica

243

393

6.40

143.78

1.4

1.1

76.57

88.29

u/ml

—

Diseases of oesophagus, stomach and duodenum

1078

2625

2.45

140.99

1.3

1.2

73.39

72.30

u/ml

0.03

Fibromyalgia

209

301

7.24

138.36

1.4

1.2

74.09

60.75

u/ml

0.21

ILD, hospital admission 2, with pulmonary infections

206

301

7.12

134.55

1.3

1.1

113.67

80.67

u/ml

—

Dyspnoea

947

2797

2.47

133.08

1.3

1.2

85.11

65.28

u/ml

0.86

Abnormalities of breathing

865

1913

2.61

127.77

1.2

93.24

61.15

u/ml

1.34

Follow-up examination after treatment for conditions other than malignant neoplasms

415

724

3.86

120.66

1.3

1.2

75.08

61.85

u/ml

0.23

Idiopathic pulmonary fibrosis

167

220

7.95

119.83

1.3

1.1

56.33

77.13

u/ml

—

Diseases of the musculoskeletal system and connective tissue

387

447

4.37

117.23

1.2

1.1

52.13

35.00

u/ml

—

General examination and investigation of persons without complaint and reported diagnosis

529

821

3.37

116.48

1.2

75.63

61.57

u/ml

0.33

Pain in limb

761

1915

2.55

110.69

1.2

78.00

57.93

u/ml

0.86

Persons encountering health services in other circumstances

479

1594

3.01

106.59

1.3

1.2

53.82

69.33

u/ml

0.29

Other disorders of skin and subcutaneous tissue

764

2706

2.41

105.74

1.3

1.2

70.89

67.94

u/ml

0.09

Other special examinations and investigations of persons without complaint or reported diagnosis

510

821

3.17

101.55

1.2

69.90

61.57

u/ml

0.18

Systemic sclerosis

15.12

101.06

1.5

1.1

40.57

—

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

932

2903

2.18

97.67

1.3

1.2

81.41

64.35

u/ml

0.77

Other (seronegative) rheumatoid arthritis, wide

283

724

4.01

97.57

1.3

1.2

71.89

72.19

u/ml

—

Diseases of the skin and subcutaneous tissue

806

1721

2.37

94.09

1.3

1.2

73.25

79.59

u/ml

0.17

Any gastric operation

611

1141

2.70

92.99

1.2

66.87

49.89

u/ml

0.51

GASTRO-related operations

611

1141

2.70

92.99

1.2

66.87

49.89

u/ml

0.51

L04AA Selective immunosuppressants

300

835

3.67

91.49

1.4

1.2

75.05

72.82

u/ml

0.04

Chronic kidney disease

355

1054

3.29

90.99

1.2

96.00

80.25

u/ml

—

General symptoms and signs

913

2091

2.20

90.64

1.3

1.2

77.20

61.67

u/ml

0.60

Asthma, unspecified (mode), excluding more controls

474

1185

2.89

90.59

1.2

96.38

65.89

u/ml

—

Continuous positive airway pressure

245

487

4.27

87.51

1.2

91.71

105.91

u/ml

—

Urticaria and erythema

427

1510

2.87

87.17

1.3

1.2

79.17

66.21

u/ml

0.32

Asthma, unspecified (mode)

481

1272

2.75

84.52

1.2

96.38

65.89

u/ml

—

Hypothyroidism, strict autoimmune

611

1637

2.47

84.41

1.3

1.2

52.39

63.92

u/ml

0.28

Fever of other and unknown origin

523

1783

2.56

83.60

1.3

1.2

56.00

60.15

u/ml

0.10

Infections, IBD-co-morbidities

133

119

7.95

82.40

1.3

1.1

51.56

—

u/ml

—

Soft tissue disorders

825

1936

2.20

82.07

1.2

70.50

56.41

u/ml

0.48

Renal failure

477

1543

2.66

81.79

1.2

83.45

81.31

u/ml

0.04

Other and unspecified urticaria

263

726

3.70

81.25

1.3

1.2

85.91

58.61

u/ml

0.56

Cough

413

1379

2.82

81.10

1.3

1.2

65.50

66.37

u/ml

0.01

Mixed connective tissue disease

17.56

79.70

1.5

1.1

76.91

—

u/ml

—

Seropositive rheumatoid arthritis, wide

328

1063

3.14

78.49

1.2

104.04

71.15

u/ml

1.07

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

320

1033

3.15

77.11

1.2

104.04

71.15

u/ml

1.07

Headache

600

1995

2.34

77.05

1.3

1.2

77.89

61.58

u/ml

0.56

Other/unspecified seropositive rheumatoid arthritis

323

1049

3.13

77.03

1.2

104.04

71.15

u/ml

1.07

Presence of other devices

286

848

3.37

76.78

1.2

77.74

83.50

u/ml

0.11

Oedema, not elsewhere classified

346

1160

2.95

74.23

1.2

96.62

75.32

u/ml

0.42

ILD medications: azathioprine

161

332

4.94

73.12

1.5

1.2

89.80

68.22

u/ml

—

Urticaria

346

1205

2.91

72.80

1.3

1.2

88.21

60.15

u/ml

0.71

All chronic kidney diseases

530

1772

2.41

72.80

1.2

75.39

82.61

u/ml

0.17

Other disorders of lacrimal gland

418

1624

2.61

71.19

1.3

1.2

85.96

72.71

u/ml

0.40

Special screening examination for infectious and parasitic diseases

207

361

4.22

70.28

1.3

51.85

51.60

u/ml

—

Arthrosis

516

1136

2.50

70.03

1.2

76.19

75.30

u/ml

0.01

Other and unspecified polyneuropathies, also in other diseases

237

676

3.57

69.80

1.3

1.2

62.62

71.19

u/ml

—

Sulfasalazine

282

900

3.17

69.16

1.2

65.00

69.81

u/ml

0.09

Gonarthrosis [arthrosis of knee](FG)

525

1241

2.45

69.09

1.2

1.1

76.23

60.15

u/ml

0.33

Polyneuropathies and other disorders of the peripheral nervous system

259

791

3.33

68.49

1.3

1.2

71.70

68.69

u/ml

—

Sleep apnoea

847

2716

1.98

68.10

1.2

69.27

69.87

u/ml

0.01

105

Asthma (only as main-diagnosis), excluding more controls

533

1227

2.42

67.40

1.2

99.75

65.89

u/ml

0.84

Internal derangement of knee

303

1013

2.99

67.11

1.2

101.00

76.12

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

785

1916

2.06

66.81

1.2

87.83

60.35

u/ml

1.19

Other arthrosis

404

1023

2.67

65.75

1.2

74.87

74.71

u/ml

0.00

Disorders of lacrimal system

466

1950

2.38

65.00

1.3

1.2

85.96

72.10

u/ml

0.44

Asthma (only as main-diagnosis)

549

1320

2.34

64.97

1.2

99.75

65.89

u/ml

0.84

Anaemias

210

336

4.05

64.43

1.2

69.86

71.13

u/ml

—

Examination and observation for other reasons

395

819

2.74

64.26

1.2

77.92

61.57

u/ml

0.29

Nerve, nerve root and plexus disorders

919

2946

1.88

63.46

1.2

69.91

70.58

u/ml

0.02

107

Persons encountering health services for examination and investigation

429

821

2.64

62.62

1.2

56.87

61.57

u/ml

0.09

Tramadol

678

1967

2.09

62.23

1.3

1.2

71.17

66.42

u/ml

0.11

Fitting and adjustment of other devices

387

1348

2.56

61.83

1.2

86.60

82.53

u/ml

0.09

Azathioprine

161

381

4.30

61.70

1.5

1.2

89.80

61.38

u/ml

—

Diseases of arteries, arterioles and capillaries

594

2069

2.12

59.66

1.3

1.2

89.64

79.51

u/ml

0.24

Shoulder lesions

609

1721

2.13

59.25

1.2

91.76

58.89

u/ml

1.07

Abnormalities of heart beat

335

1249

2.63

57.89

1.3

1.2

81.22

69.02

u/ml

—

Pain in throat and chest

645

1877

2.04

56.18

1.2

86.36

61.15

u/ml

1.00

Bacterial infection, other or unspecified, including avohilmo

530

2043

2.14

55.91

1.3

1.2

86.71

77.66

u/ml

0.21

Excluding asthma or asthma-COPD overlap

573

1328

2.17

55.63

1.2

62.92

65.89

u/ml

0.07

Coxarthrosis [arthrosis of hip](FG)

374

1032

2.51

54.58

1.2

1.1

55.00

69.80

u/ml

0.21

All kidney diseases

821

3000

1.84

54.43

1.2

74.24

69.16

u/ml

0.15

107

Codeine

751

2115

1.93

54.38

1.2

95.50

64.13

u/ml

0.96

Asthma, excluding more controls

528

1227

2.22

54.37

1.2

91.78

65.89

u/ml

—

Bacterial infection, other or unspecified

484

1888

2.18

53.71

1.3

1.2

80.22

79.19

u/ml

0.02

Renal tubulo-interstitial diseases

736

2875

1.89

53.43

1.2

76.50

67.98

u/ml

0.26

102

Sleep apnoea, including avohilmo

838

2781

1.83

53.29

1.2

63.66

70.00

u/ml

0.17

109

Persons encountering health services in other circumstances, wide

903

2577

1.81

53.17

1.3

1.2

79.84

64.93

u/ml

0.49

Other pulmonary diagnosis

565

1328

2.14

53.04

1.2

66.96

65.89

u/ml

0.02

Codeine or tramadol medication

918

2811

1.78

52.15

1.2

87.92

64.94

u/ml

0.83

113

Gonarthrosis

437

1061

2.34

52.14

1.2

80.55

75.30

u/ml

0.09

Missing teeth due to accident, extraction or parodontitis

552

2436

2.04

52.06

1.2

70.71

74.53

u/ml

0.10

Other diseases of intestines

839

2573

1.83

51.81

1.3

1.2

79.38

67.13

u/ml

0.43

Iron deficiency anaemia

408

1776

2.27

51.65

1.2

99.29

77.67

u/ml

0.58

Asthma

544

1320

2.14

51.16

1.2

91.78

65.89

u/ml

—

Other intervertebral disc disorders

675

2084

1.94

51.09

1.2

72.65

66.89

u/ml

0.15

Nutritional anaemias

455

2028

2.16

50.34

1.2

99.87

78.30

u/ml

0.64

COPD differential diagnosis

566

1366

2.09

49.80

1.2

62.92

64.92

u/ml

0.05

ILD differential diagnosis

566

1366

2.09

49.79

1.2

62.92

64.92

u/ml

0.05

Parasetamol

499

1165

2.18

48.84

1.2

75.41

47.38

u/ml

0.92

Symptoms and signs involving the skin and subcutaneous tissue

630

3165

1.89

48.35

1.3

1.2

84.68

66.48

u/ml

0.70

107

Heart failure, not strict

606

2094

1.96

48.24

1.2

67.90

82.85

u/ml

0.42

Glomerular diseases

188

588

3.25

47.98

1.2

72.17

76.28

u/ml

—

Asthma (mode)

539

1366

2.08

47.88

1.2

91.78

64.92

u/ml

—

Symptoms and signs involving the urinary system

635

2529

1.91

47.85

1.2

76.20

73.85

u/ml

0.06

Episodal and paroxysmal disorders

836

2378

1.79

47.57

1.3

1.2

81.65

69.78

u/ml

0.36

Disorders of eyelid, lacrimal system and orbit

733

2984

1.81

46.79

1.3

1.2

69.32

71.07

u/ml

0.05

103

Other diseases of pleura

390

1525

2.24

46.68

1.3

1.2

77.57

75.21

u/ml

0.04

Dorsalgia

755

2203

1.82

46.10

1.3

1.2

77.00

64.91

u/ml

0.37

Osteopathies and chondropathies

498

2272

2.02

45.93

1.3

1.2

72.00

72.15

u/ml

0.00

Other symptoms and signs involving the digestive system and abdomen

189

609

3.15

45.90

1.3

1.2

74.40

75.15

u/ml

—

Low back pain

615

2183

1.91

45.86

1.3

1.2

61.09

65.64

u/ml

0.12

Atopic dermatitis

482

1880

2.05

45.56

1.3

1.2

63.24

67.11

u/ml

0.09

Spondylopathies

624

1937

1.92

45.38

1.2

88.00

66.44

u/ml

0.58

Pruritus

137

362

3.85

45.35

1.3

1.2

92.67

58.18

u/ml

—

Sleep disorders (combined)

857

2581

1.74

44.80

1.2

66.54

71.41

u/ml

0.14

Pneumonia, organism unspecified

740

2859

1.78

44.50

1.3

1.2

76.69

65.41

u/ml

0.35

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

227

367

3.12

44.46

1.2

38.62

63.08

u/ml

—

Implicit Sepsis

621

2459

1.87

44.16

1.2

83.08

73.14

u/ml

0.29

Other and unspecified iron deficiency

323

1389

2.34

44.12

1.2

94.70

70.69

u/ml

—

Pain, not elsewhere classified

258

1006

2.59

43.81

1.3

1.2

37.13

65.75

u/ml

—

Other diseases of upper respiratory tract

821

2452

1.75

43.75

1.2

87.81

68.26

u/ml

0.73

Meniscus derangement

364

1057

2.30

43.69

1.2

84.00

72.33

u/ml

0.20

Opioids

739

2122

1.81

43.51

1.2

86.77

64.13

u/ml

0.86

Neurological diseases

605

1582

1.93

43.19

1.2

67.56

66.13

u/ml

0.03

Implicit Sepsis, including avohilmo

662

2617

1.82

42.66

1.2

81.36

71.01

u/ml

0.32

Coxibs

191

304

3.32

41.76

1.2

68.60

60.80

u/ml

—

Seropositive rheumatoid arthritis, strict definition

174

568

3.12

41.46

1.2

78.42

73.78

u/ml

0.06

Coxarthrosis

334

927

2.34

41.43

1.2

60.00

78.27

u/ml

—

Pain (limb, back, neck, head abdominally)

467

1125

2.09

41.41

1.2

81.06

60.75

u/ml

0.55

Other dorsopathies, not elsewhere classified

748

2203

1.77

41.38

1.2

76.08

64.91

u/ml

0.37

Malaise and fatigue

408

1535

2.11

41.15

1.3

1.2

69.17

64.88

u/ml

0.11

Persons encountering health services for other counselling and medical advice, not elsewhere classified

827

2576

1.71

40.99

1.3

1.2

80.50

64.93

u/ml

0.54

Other bacterial diseases, including avohilmo

790

2892

1.71

40.58

1.2

76.50

66.35

u/ml

0.35

103

Other bacterial diseases

734

2814

1.74

40.00

1.2

74.39

69.60

u/ml

0.14

Rheumatism, unspecified

150

459

3.32

39.80

1.3

1.2

131.20

86.22

u/ml

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

416

1990

2.03

39.48

1.3

1.2

99.38

66.20

u/ml

—

Disorders of synovium and tendon

409

1699

2.05

39.27

1.2

63.33

59.85

u/ml

—

Other abnormal uterine and vaginal bleeding

230

627

2.67

38.29

1.3

53.17

86.64

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

687

2293

1.76

38.25

1.3

1.2

77.23

65.99

u/ml

0.32

687

2293

1.76

38.25

1.3

1.2

77.23

65.99

u/ml

0.32

Lower back pain or/and sciatica

841

3181

1.65

37.63

1.3

1.2

63.57

71.05

u/ml

0.25

114

Condition for Implicit Sepsis (Organ dysfunction codes)

668

2662

1.75

37.62

1.2

81.36

70.41

u/ml

0.34

Chronic gastritis

230

915

2.54

37.57

1.3

1.2

72.83

85.49

u/ml

—

Certain infectious and parasitic diseases

707

2033

1.75

37.26

1.2

62.33

69.56

u/ml

0.23

Symptoms and signs involving the digestive system and abdomen

698

2002

1.75

37.16

1.2

68.19

62.53

u/ml

0.15

Irritable bowel syndrome

259

1095

2.39

37.08

1.3

1.2

85.09

67.60

u/ml

0.29

Migraine

424

1666

1.99

36.85

1.3

1.2

65.79

62.27

u/ml

0.07

Cardiovascular diseases

427

1114

2.04

36.42

1.3

1.2

53.36

56.65

u/ml

0.06

Gastrointestinal diseases

398

949

2.11

36.35

1.2

68.88

51.74

u/ml

0.40

Certain disorders involving the immune mechanism

190

701

2.75

36.24

1.2

79.75

74.04

u/ml

0.09

Other diseases of lip and oral mucosa

384

1917

2.02

36.23

1.3

1.2

79.71

70.71

u/ml

0.26

Diseases of liver

310

1430

2.19

36.09

1.2

65.69

85.51

u/ml

0.54

Substance use, excluding alcohol

193

720

2.71

35.99

1.3

1.2

36.67

61.11

u/ml

—

Influenza and pneumonia

803

3035

1.64

35.01

1.3

1.2

78.30

65.43

u/ml

0.41

104

Methotrexate

134

415

3.27

34.89

1.2

107.56

69.35

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

771

3066

1.65

34.82

1.3

1.2

76.21

66.61

u/ml

0.30

105

Chronic diseases of tonsils and adenoids

584

2079

1.78

34.49

1.3

1.2

63.43

65.96

u/ml

0.06

Disorders of the thyroid gland

730

2852

1.67

34.37

1.3

1.2

46.88

75.89

u/ml

1.69

Hallux valgus (acquired)

235

680

2.49

34.31

1.2

80.57

69.09

u/ml

—

Abdominal and pelvic pain

684

2002

1.72

34.26

1.2

71.21

62.53

u/ml

0.25

Hypothyroidism, other/unspecified

693

2711

1.69

34.26

1.3

1.2

49.79

74.77

u/ml

1.24

Hypothyreosis and Thyroxine purchase for inclusion criteria

720

2845

1.66

33.78

1.3

1.2

48.64

76.87

u/ml

1.55

Any reimbursement code in KELA

398

979

2.05

33.62

1.3

1.2

51.36

54.00

u/ml

0.05

Other heart diseases, wide

687

2471

1.69

33.53

1.2

64.57

66.36

u/ml

0.05

Mycoses

258

1141

2.28

33.37

1.3

1.2

78.21

65.15

u/ml

0.29

Budesonide

126

387

3.30

33.25

1.3

1.2

41.80

71.40

u/ml

—

All pneumoniae

768

3073

1.63

33.16

1.3

1.2

76.21

65.99

u/ml

0.32

106

Infections with a predominantly sexual mode of transmission

267

1199

2.24

33.05

1.3

46.11

64.63

u/ml

0.55

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

751

3072

1.63

32.93

1.3

1.2

72.97

67.14

u/ml

0.16

108

Diseases of the myoneural junction and muscle

131

417

3.19

32.68

1.3

1.2

88.44

69.15

u/ml

—

Convalescence

178

4.56

32.58

1.2

72.00

56.17

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

681

2767

1.67

32.42

1.2

84.50

65.15

u/ml

0.72

Hypothyroidism, strict autoimmune, 3 medication purchases required

671

2705

1.67

32.36

1.3

1.2

54.06

75.61

u/ml

0.92

Rotator cuff syndrome

439

1606

1.89

32.12

1.2

87.00

62.75

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

726

2817

1.63

31.58

1.2

59.36

69.11

u/ml

0.36

Hernia of abdominal wall, postoperative

133

433

3.08

31.38

1.1

1.2

142.40

58.69

u/ml

—

Diseases of the ear and mastoid process

832

2629

1.59

30.92

1.2

77.13

63.55

u/ml

0.48

Other/unspecified rheumatoid arthritis

136

458

3.02

30.85

1.3

1.2

77.89

61.94

u/ml

—

Rosacea

142

491

2.94

30.71

1.3

1.2

96.80

63.06

u/ml

—

Concussion

349

1365

1.99

30.48

1.2

90.26

66.60

u/ml

0.73

Other/unspecified dorsalgia

302

1453

2.07

30.46

1.3

1.2

66.55

64.16

u/ml

0.04

Other heart diseases

357

1170

1.99

30.09

1.2

58.46

63.33

u/ml

0.09

Haemorrhoids and perianal venous thrombosis

281

1338

2.10

29.63

1.3

1.2

65.71

77.67

u/ml

0.26

Visual disturbances and blindness

426

2356

1.82

29.42

1.3

1.2

73.85

74.25

u/ml

0.01

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

352

1121

1.99

29.31

1.3

1.2

73.00

60.82

u/ml

—

Pollen allergy

166

629

2.63

29.18

1.3

1.2

33.20

53.04

u/ml

—

Atopic dermatitis, strict definition with reimbursement

224

946

2.29

29.16

1.3

1.2

38.29

53.29

u/ml

—

Polycystic ovarian syndrome, consortium definition

598

2037

1.69

29.11

1.3

42.00

72.26

u/ml

1.76

Carpal tunnel syndrome

484

2406

1.75

28.89

1.2

63.92

72.08

u/ml

0.14

Vasomotor and allergic rhinitis

288

1375

2.06

28.80

1.3

1.2

46.67

64.09

u/ml

—

Candidiasis, including avohilmo

273

1311

2.10

28.79

1.3

1.2

86.45

66.52

u/ml

0.63

Syncope and collapse

325

1371

1.99

28.73

1.2

88.93

73.46

u/ml

0.40

Dorsopathies

705

2205

1.62

28.63

1.2

81.36

64.11

u/ml

0.61

Other functional intestinal disorders

351

1670

1.92

28.41

1.3

1.2

95.71

71.05

u/ml

0.78

Aplastic and other anaemias

361

1752

1.90

28.17

1.3

1.2

96.56

82.06

u/ml

—

Intracranial trauma

385

1381

1.89

28.16

1.2

91.43

66.60

u/ml

0.77

Other headache syndromes

337

1751

1.93

28.13

1.3

1.2

80.43

67.18

u/ml

0.33

Diseases of salivary glands

283

1397

2.04

27.72

1.3

1.2

82.25

74.71

u/ml

0.15

Other diseases of liver

172

692

2.52

27.66

1.2

82.60

75.58

u/ml

—

Hypothyroidism (congenital or acquired)

169

349

2.73

27.65

1.3

1.2

35.10

71.13

u/ml

—

Diverticular disease of intestine

517

1872

1.73

27.63

1.2

67.90

76.86

u/ml

0.22

Disorders of skin appendages

396

2177

1.82

27.52

1.3

1.2

73.33

64.22

u/ml

0.20

Enlarged lymph nodes

137

493

2.81

27.50

1.3

1.2

81.00

65.28

u/ml

—

Hypothyroidism, levothyroxine purchases

168

348

2.72

27.40

1.3

1.2

35.10

71.13

u/ml

—

Hypothyroidism and >3 levothyroxin purchases

168

348

2.72

27.40

1.3

1.2

35.10

71.13

u/ml

—

Diseases of the respiratory system

419

1133

1.86

27.21

1.2

67.94

59.42

u/ml

0.17

Inflammatory diseases of female pelvic organs

533

2164

1.69

27.09

1.3

58.48

68.89

u/ml

0.40

Complications of surgical and medical care, not elsewhere classified

741

3179

1.56

27.00

1.2

69.50

70.35

u/ml

0.02

109

Other and unspecified anaemias

335

1654

1.91

26.97

1.3

1.2

96.56

81.84

u/ml

—

Hypothyroidism, drug reimbursement

116

254

3.22

26.86

1.3

1.2

21.83

71.13

u/ml

—

Cervical disc disorders

283

1413

2.02

26.85

1.2

68.20

67.18

u/ml

—

Unspecified kidney failure

100

305

3.33

26.82

1.2

1.1

98.00

82.25

u/ml

—

Pain associated with micturition

121

414

2.96

26.72

1.2

72.00

64.18

u/ml

—

Implicit bacterial Sepsis, including avohilmo

352

1561

1.89

26.62

1.2

71.67

83.74

u/ml

0.22

Dizziness and giddiness

584

2790

1.63

26.55

1.2

64.60

71.23

u/ml

0.17

102

Other anaemias

336

1668

1.90

26.37

1.3

1.2

96.56

81.11

u/ml

—

Implicit viral Sepsis, including avohilmo

251

1206

2.09

26.30

1.2

97.00

78.95

u/ml

—

Oxycodone

300

1306

1.98

26.16

1.2

63.94

78.51

u/ml

0.29

Dysphagia

202

895

2.28

26.13

1.4

1.2

105.10

81.21

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

181

766

2.39

26.07

1.2

62.20

68.58

u/ml

—

Asthma (diagnoses ohter than nonallergic)

649

3335

1.58

25.66

1.2

100.73

66.82

u/ml

0.79

131

Caries of dentine

172

691

2.42

25.42

1.3

1.2

85.67

75.00

u/ml

0.18

Heart failure,strict

379

1451

1.83

25.35

1.2

72.00

86.34

u/ml

0.31

Other enthesopathies

221

1039

2.14

24.67

1.3

1.2

101.44

59.11

u/ml

—

Bacterial Sepsis

354

1602

1.84

24.65

1.3

1.2

71.50

84.65

u/ml

0.26

Chronic apical periodontitis

807

3004

1.51

24.64

1.2

76.84

67.29

u/ml

0.30

103

Oter anti-inflammatory and antirheumatic agents, non-steroids

136

260

2.89

24.59

1.2

1.1

92.86

66.67

u/ml

—

COPD/asthma/ILD related infections

712

2293

1.56

24.53

1.3

1.2

76.00

65.99

u/ml

0.32

COPD/asthma related infections

712

2293

1.56

24.53

1.3

1.2

76.00

65.99

u/ml

0.32

Dialysis, with operation codes

112

386

2.94

24.45

1.3

1.2

99.60

64.91

u/ml

—

Other disorders of urethra and urinary system

543

2318

1.64

24.37

1.2

87.79

66.04

u/ml

0.57

Papulosquamous disorders

320

1725

1.87

24.25

1.3

1.2

70.58

84.87

u/ml

0.34

Complications of medical and surgical care

560

3151

1.60

24.16

1.2

74.78

69.48

u/ml

0.12

121

Implicit bacterial Sepsis

317

1451

1.88

24.07

1.2

71.67

81.36

u/ml

0.17

Osteoporosis

227

996

2.11

24.03

1.3

1.2

88.25

76.80

u/ml

0.20

814

2754

1.50

23.73

1.3

1.2

68.10

68.74

u/ml

0.02

Obesity due to excess calories

386

2216

1.75

23.72

1.2

77.00

67.72

u/ml

0.18

Disorders of lens

463

1693

1.70

23.65

1.3

1.2

71.59

78.67

u/ml

0.18

Presence of other functional implants

425

1686

1.73

23.60

1.2

71.41

83.41

u/ml

0.33

Diaphragmatic hernia

294

1557

1.90

23.57

1.3

1.2

66.08

89.15

u/ml

0.45

Functional dyspepsia

209

981

2.15

23.50

1.2

66.75

73.60

u/ml

—

Sciatica+with lumbago

380

1926

1.76

23.09

1.3

1.2

53.92

67.27

u/ml

0.32

Obesity related asthma

289

1533

1.90

23.07

1.2

101.29

70.22

u/ml

—

Haemorrhage from respiratory passages

232

1003

2.06

22.93

1.2

51.42

84.89

u/ml

0.81

Spinal stenosis

360

1484

1.80

22.91

1.2

86.62

72.20

u/ml

0.27

Symptoms and signs involving cognition, perception, emotional state and behaviour

703

3101

1.52

22.86

1.2

59.35

72.52

u/ml

0.49

114

Other predominantly sexually transmitted diseases, not elsewhere classified

151

626

2.44

22.85

1.4

1.3

66.44

60.54

u/ml

—

Heart failure and antihypertensive medication

182

510

2.34

22.81

1.2

46.38

90.29

u/ml

—

Menorrhagia

268

744

2.02

22.74

1.2

1.3

72.40

82.54

u/ml

—

Dental caries

182

770

2.25

22.67

1.3

1.2

85.67

73.88

u/ml

0.21

Cardiovascular diseases (excluding rheumatic etc)

431

1435

1.72

22.67

1.2

1.3

78.53

58.09

u/ml

0.47

Follow-up care involving plastic surgery

133

4.41

22.61

1.2

—

32.40

—

Candidiasis

140

564

2.51

22.57

1.3

1.2

83.62

68.95

u/ml

0.29

Mycoses, including avohilmo

670

3362

1.52

22.47

1.3

1.2

91.20

63.88

u/ml

1.21

112

Benzodiazepine use

727

3277

1.50

22.43

1.2

84.46

64.32

u/ml

0.98

107

Lumbar disc prolapse

452

2009

1.67

22.42

1.2

56.33

67.78

u/ml

0.31

Pain and other conditions associated with female genital organs and menstrual cycle

180

670

2.26

22.29

1.3

76.40

78.56

u/ml

—

Osteoporosis with pathological fracture (FG)

156

4.03

22.17

1.3

1.1

68.00

90.17

u/ml

—

Localized swelling, mass and lump of skin and subcutaneous tissue

256

1327

1.94

21.94

1.2

96.63

70.52

u/ml

0.69

Temporomandibular joint disorders, including avohilmo

363

2027

1.74

21.89

1.3

1.2

66.82

62.21

u/ml

0.12

Other disorders of ear

658

2794

1.53

21.78

1.2

82.45

68.17

u/ml

0.53

101

Pleural effusion

127

497

2.58

21.75

1.3

1.1

49.40

78.79

u/ml

—

Diseases of external ear

278

1485

1.89

21.75

1.2

55.38

76.75

u/ml

—

Infections of the skin and subcutaneous tissue

424

2514

1.67

21.72

1.3

1.2

65.10

68.95

u/ml

0.09

Exposure to other specified factors

588

3278

1.55

21.57

1.2

63.96

69.11

u/ml

0.12

114

Disturbances of skin sensation

225

1124

2.02

21.47

1.4

1.2

67.00

64.26

u/ml

—

Disorders of muscles

285

3.13

21.46

1.3

1.2

121.60

73.44

u/ml

—

Visual disturbances

374

2193

1.72

21.36

1.3

1.2

70.00

72.61

u/ml

0.07

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

686

2886

1.51

21.29

1.3

1.2

80.00

67.29

u/ml

0.31

108

Neurotic, stress-related and somatoform disorders

641

2907

1.52

21.29

1.3

1.2

70.04

68.11

u/ml

0.05

111

Asthma, hospital admissions , main diagnosis only

590

3348

1.54

21.24

1.2

99.75

65.50

u/ml

0.90

131

Anxiety disorders

646

2926

1.52

21.16

1.3

1.2

70.04

68.11

u/ml

0.05

111

Subjective visual disturbances

218

1083

2.03

21.15

1.3

1.2

70.40

65.40

u/ml

0.12

Noninfective enteritis and colitis

342

1961

1.75

21.05

1.3

1.2

80.00

70.00

u/ml

0.15

Infections with a predominantly sexual mode of transmission, including avohilmo

297

1490

1.83

21.04

1.3

49.90

62.67

u/ml

0.38

Soft tissue disorders related to use, overuse and pressure

199

960

2.09

20.89

1.2

119.56

77.31

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

137

568

2.44

20.78

1.2

75.00

59.42

u/ml

—

Artrosis, including avohilmo

542

1872

1.59

20.77

1.2

88.58

69.68

u/ml

0.49

Chronic sinusitis

303

1686

1.80

20.69

1.3

1.2

105.86

67.54

u/ml

—

Polyuria

176

815

2.18

20.58

1.2

53.25

80.72

u/ml

—

Spondylosis

382

1764

1.70

20.35

1.3

1.2

87.80

70.97

u/ml

—

Chronic rhinitis, nasopharyngitis and pharyngitis

243

1272

1.92

20.24

1.2

98.22

68.29

u/ml

—

Other skin changes

169

776

2.20

20.21

1.3

1.2

52.57

74.25

u/ml

—

Anxiety disorders, excluding more controls

596

2490

1.53

20.19

1.3

1.2

70.04

66.66

u/ml

0.09

Implicit viral Sepsis

163

739

2.22

20.10

1.2

96.38

60.48

u/ml

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

647

3379

1.50

20.09

1.3

1.2

61.68

70.76

u/ml

0.35

118

Benign neoplasm of colon, rectum, anus and anal canal

457

2409

1.61

20.02

1.3

1.2

69.64

79.74

u/ml

0.24

Viral Sepsis

163

741

2.22

19.97

1.2

96.38

60.48

u/ml

—

Disease of hard tissues of teeth, NOS

357

1067

1.76

19.76

1.2

98.00

71.06

u/ml

—

Antihypertensive medication - note that there are other indications

391

1198

1.71

19.69

1.2

1.3

59.50

49.70

u/ml

—

Acute upper respiratory infections

735

3019

1.46

19.59

1.2

66.64

68.58

u/ml

0.06

102

Other hammer toe(s) (acquired)

116

413

2.58

19.47

1.3

1.2

154.20

87.86

u/ml

—

Symptoms and signs involving the nervous and musculoskeletal systems

425

2640

1.62

19.42

1.2

70.86

70.37

u/ml

0.01

Sensorineural hearing loss

525

2250

1.56

19.38

1.2

76.13

74.35

u/ml

0.05

Diseases of arteries, arterioles and capillaries (FINNGEN)

179

572

2.17

19.37

1.2

95.25

94.86

u/ml

0.00

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

163

751

2.19

19.33

1.4

1.3

69.30

57.93

u/ml

—

Diagnoses used for exclusion with ILD

193

949

2.05

19.30

1.2

91.42

69.25

u/ml

0.38

Asthma-related infections

425

2576

1.61

19.28

1.2

111.20

66.62

u/ml

—

113

Asthma, hospital admission 2, infections

425

2576

1.61

19.28

1.2

111.20

66.62

u/ml

—

113

Recurrent or chronic depression

303

1174

1.80

19.27

1.2

88.85

65.92

u/ml

0.55

Allergic rhinitis

231

1194

1.92

19.24

1.3

1.2

50.38

58.85

u/ml

—

Heart failure, strict

405

1711

1.65

19.03

1.2

76.94

82.09

u/ml

0.10

Conductive and sensorineural hearing loss

547

2370

1.54

18.88

1.2

88.54

71.49

u/ml

0.60

All-cause Heart Failure

400

1691

1.65

18.82

1.2

76.94

83.51

u/ml

0.13

Abnormal findings on examination of blood, without diagnosis

331

1759

1.71

18.57

1.3

1.2

78.86

72.04

u/ml

—

Gonarthrosis,primary

622

2516

1.50

18.54

1.2

73.47

72.65

u/ml

0.02

Non-ischemic cardiomyopathy

243

1026

1.89

18.54

1.2

89.43

91.78

u/ml

0.04

Senile cataract

411

1525

1.65

18.52

1.2

67.16

83.23

u/ml

0.44

Striking against or struck by other objects

232

1232

1.89

18.47

1.2

76.87

66.48

u/ml

—

Explicit Sepsis, including avohilmo

319

1686

1.72

18.38

1.3

1.2

65.90

81.64

u/ml

0.39

Benign neoplasm: Colon

392

2269

1.63

18.32

1.2

80.90

82.76

u/ml

—

Triptan medication for migraine, min. 3 purchases

428

1999

1.61

18.27

1.3

83.09

58.80

u/ml

0.54

Diseases of the eye and adnexa

496

1578

1.58

18.22

1.3

1.2

62.20

71.72

u/ml

0.25

Injuries to the wrist and hand

713

3280

1.44

18.20

1.3

1.2

53.67

71.26

u/ml

0.63

118

Cardiac arrhythmias

421

1673

1.62

18.03

1.2

1.3

58.71

71.40

u/ml

0.28

Persons encountering health services for specific procedures and health care

731

3001

1.44

18.02

1.2

1.3

77.59

66.62

u/ml

0.39

108

Bronchitis

762

3206

1.43

18.02

1.3

1.2

74.94

68.34

u/ml

0.21

109

Depression

669

3077

1.46

17.92

1.2

66.63

68.30

u/ml

0.04

116

Explicit Sepsis

311

1654

1.72

17.85

1.3

1.2

65.90

79.96

u/ml

0.34

Lyme disease

264

1479

1.80

17.84

1.2

79.30

78.93

u/ml

—

Lyme disease, including avohilmo

264

1479

1.80

17.84

1.2

79.30

78.93

u/ml

—

Other spirochaetal diseases, including avohilmo

267

1503

1.79

17.75

1.2

79.30

79.96

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

155

727

2.15

17.63

1.3

1.2

67.18

69.52

u/ml

0.04

Other nutritional deficiencies

491

2938

1.53

17.61

1.2

82.00

66.05

u/ml

0.43

111

Spirochaetal infections, other/unspecified, including avohilmo

264

1486

1.79

17.57

1.2

79.30

79.96

u/ml

—

Open wound of wrist and hand

305

1725

1.72

17.52

1.3

1.2

65.60

69.73

u/ml

—

Other symptoms and signs involving the nervous and musculoskeletal systems

311

1834

1.70

17.51

1.2

81.67

75.85

u/ml

0.12

Other spirochaetal diseases

264

1489

1.79

17.45

1.2

79.30

79.96

u/ml

—

323

1914

1.68

17.31

1.2

111.20

64.08

u/ml

—

Other disorders of veins

319

1871

1.69

17.23

1.3

1.2

75.44

69.29

u/ml

—

Gonarthrosis, primary, with knee surgery

410

2007

1.60

17.21

1.2

95.70

78.19

u/ml

—

Erysipelas, including avohilmo

485

2344

1.54

17.18

1.2

79.74

74.51

u/ml

0.13

L04AC Interleukin inhibitors

218

3.17

17.00

1.2

—

48.60

—

Stomatitis and related lesions

160

771

2.09

16.99

1.2

99.17

67.94

u/ml

—

Genitourinary diseases

314

905

1.75

16.90

1.2

62.27

70.20

u/ml

0.12

Other arrhythmias

440

2107

1.56

16.85

1.2

74.71

65.95

u/ml

0.21

Mood disorders, excluding more controls

653

2651

1.45

16.76

1.2

71.85

66.66

u/ml

0.13

Excessive, frequent and irregular menstruation

271

803

1.81

16.68

1.2

1.3

49.30

82.54

u/ml

—

Migraine with aura

185

945

1.97

16.67

1.3

1.2

56.92

43.30

u/ml

0.31

Migraine with aura and triptan purchases

136

620

2.21

16.66

1.3

76.29

52.26

u/ml

—

Chronic lower respiratory diseases

807

3042

1.40

16.64

1.2

83.06

65.93

u/ml

0.41

123

Other female pelvic inflammatory diseases

143

666

2.17

16.63

1.2

61.11

74.82

u/ml

—

Dental operations

370

1152

1.66

16.62

1.2

77.46

74.74

u/ml

0.04

Other antidepressants

677

2395

1.45

16.60

1.2

82.82

68.74

u/ml

0.42

Septicaemia

287

1528

1.72

16.53

1.3

1.2

65.90

83.75

u/ml

0.44

Artificial joint operation, meniscal resection

615

2708

1.46

16.35

1.2

78.68

70.92

u/ml

0.18

103

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

416

2675

1.56

16.34

1.2

73.07

69.78

u/ml

0.07

105

Disorders of conjunctiva

588

3130

1.46

16.32

1.3

1.2

54.89

73.03

u/ml

0.99

106

Sarcoidosis

109

457

2.41

16.27

1.2

109.00

66.75

u/ml

—

Mood disorders

701

3167

1.42

16.18

1.2

67.22

68.73

u/ml

0.04

117

Constipation

620

2908

1.45

16.18

1.2

107.59

64.70

u/ml

1.66

117

Complications of procedures, not elsewhere classified

565

3113

1.47

16.16

1.2

67.04

70.35

u/ml

0.08

109

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

435

2782

1.54

16.15

1.2

69.25

69.28

u/ml

0.00

111

Diseases of inner ear

395

2412

1.57

16.12

1.2

82.42

74.30

u/ml

0.22

Psoriasis

213

1154

1.86

16.12

1.3

1.2

63.00

72.13

u/ml

—

Mood [affective] disorders

699

3166

1.42

16.07

1.2

66.73

68.81

u/ml

0.05

118

Fibrosis and cirrhosis of liver

263

2.90

16.06

1.2

1.1

42.83

78.00

u/ml

—

Immunodeficiencies

142

3.66

15.94

1.2

26.86

36.33

u/ml

—

Disorders of choroid and retina

542

2572

1.48

15.87

1.2

84.15

72.55

u/ml

0.34

Disorders of vestibular function (Vertigo)

345

2087

1.62

15.86

1.2

78.00

77.80

u/ml

0.00

Migraine, single triptan purchase ok & required. ICD-code if available is included

530

2421

1.49

15.84

1.2

1.3

72.87

62.03

u/ml

0.32

Triptan medication for migraine, single purchase ok

530

2421

1.49

15.84

1.2

1.3

72.87

62.03

u/ml

0.32

Conjunctivitis (acute, non atopic), including avohilmo

680

2894

1.42

15.77

1.2

78.56

71.57

u/ml

0.23

Other septicaemia, including avohilmo

262

1423

1.74

15.70

1.3

1.2

65.74

80.28

u/ml

0.32

Periodontitis

685

3093

1.42

15.60

1.2

60.37

72.91

u/ml

0.50

111

Other diseases of anus and rectum

211

1147

1.84

15.59

1.3

1.2

66.10

79.14

u/ml

—

Problems related to lifestyle

318

2.67

15.53

1.4

1.2

70.29

48.11

u/ml

—

Chronic periodontitis, including avohilmo

683

3095

1.41

15.35

1.2

60.37

72.91

u/ml

0.50

111

Acute upper respiratory infections of multiple and unspecified sites

523

2592

1.48

15.27

1.3

1.2

78.92

66.94

u/ml

0.40

Disorders of sclera, cornea, iris and ciliary body

385

2479

1.56

15.27

1.2

78.42

69.32

u/ml

0.28

Other disorders involving the immune mechanism, not elsewhere classified

4.60

15.24

1.3

1.1

—

43.20

—

Depression or dysthymia

451

1605

1.54

15.22

1.2

70.43

69.89

u/ml

0.01

Diseases of oral cavity, salivary glands and jaws

344

1080

1.65

15.14

1.2

76.83

71.06

u/ml

0.09

Other septicaemia

255

1397

1.73

15.10

1.3

1.2

65.74

81.81

u/ml

0.36

Certain infectious and parasitic diseases, including avohilmo

442

1434

1.55

15.04

1.2

69.16

65.00

u/ml

0.09

Allergic urticaria

251

2.86

14.99

1.3

1.2

86.86

42.58

u/ml

—

Propionic acid derivatives

137

308

2.25

14.93

1.2

38.43

60.80

u/ml

—

Acute sinusitis

370

2152

1.57

14.87

1.3

1.2

57.57

62.16

u/ml

0.10

Hypertensive diseases (excluding secondary)

332

1182

1.64

14.80

1.2

1.3

72.73

61.26

u/ml

0.23

Atopic dermatitis, strict definition

208

1123

1.82

14.78

1.3

38.29

58.98

u/ml

—

Enthesopathies of lower limb, excluding foot

168

870

1.94

14.65

1.2

110.00

53.56

u/ml

—

Otitis externa

171

891

1.93

14.65

1.3

1.2

52.67

68.97

u/ml

—

Inflammatory bowel disease

222

1261

1.77

14.42

1.2

55.83

69.75

u/ml

—

All anxiety disorders

429

2206

1.51

14.35

1.3

1.2

76.38

66.10

u/ml

0.25

Other reaction to severe stress, and adjustment disorders

255

1509

1.70

14.25

1.3

1.2

74.58

56.86

u/ml

0.46

Other diseases of hard tissues of teeth

338

1080

1.63

14.24

1.2

75.77

71.06

u/ml

0.08

Chronic periodontitis, complicated

393

2519

1.53

14.13

1.2

44.11

78.72

u/ml

1.66

Cellulitis

160

826

1.95

14.11

1.3

1.2

72.55

80.04

u/ml

0.13

Heartburn

364

2.47

14.08

1.3

1.2

82.60

68.93

u/ml

—

Unspecified fall

345

2171

1.57

13.94

1.2

68.69

79.09

u/ml

0.23

Other dialysis

4.37

13.90

1.3

1.1

—

43.20

—

Obesity and other hyperalimentation

452

2887

1.48

13.80

1.2

1.3

77.00

67.66

u/ml

0.19

112

Unspecified haematuria

270

1324

1.67

13.72

1.2

98.91

79.34

u/ml

0.51

Caries of dentine, including avohilmo

488

1687

1.48

13.69

1.2

74.95

62.54

u/ml

0.33

Adverse effects, not elsewhere classified

151

773

1.97

13.67

1.3

1.2

64.25

71.03

u/ml

—

Asthma, including avohilmo

778

3161

1.36

13.58

1.2

83.00

66.98

u/ml

0.33

130

Obesity

449

2878

1.47

13.58

1.2

1.3

77.00

67.66

u/ml

0.19

112

Injuries to the knee and lower leg

791

3163

1.35

13.54

1.2

58.00

70.88

u/ml

0.47

115

Psoriasis vulgaris

138

688

2.02

13.48

1.2

75.20

73.19

u/ml

—

Other anxiety disorders

318

1711

1.59

13.38

1.3

1.2

78.71

60.39

u/ml

0.44

Other noninfective gastroenteritis and colitis

174

940

1.86

13.35

1.3

1.2

82.00

65.42

u/ml

—

Anxiety (asthma-related co-morbidities)

421

2147

1.50

13.28

1.3

81.40

61.20

u/ml

0.57

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.48

13.14

1.2

1.1

—

43.20

—

Intestinal infectious diseases, including avohilmo, including avohilmo

759

3125

1.36

13.14

1.3

1.2

59.31

70.93

u/ml

0.43

113

Acute tubulo-interstitial nephritis

415

2358

1.49

13.09

1.2

76.80

70.98

u/ml

0.14

Glomerulonephritis

311

2.54

13.07

1.2

70.80

71.88

u/ml

—

Caries of enamel

650

3088

1.38

12.98

1.2

50.78

72.19

u/ml

0.87

114

Ankylosing spondylitis

260

2.68

12.96

1.3

1.2

—

12.40

—

Valvular heart disease excluding rheumatic fever

295

1310

1.61

12.94

1.3

1.2

68.21

84.27

u/ml

0.36

Non-rheumatic valve diseases

294

1306

1.61

12.84

1.3

1.2

68.21

84.27

u/ml

0.36

Diseases of pulp and periapical tissues, including avohilmo

671

2520

1.38

12.83

1.2

72.31

63.20

u/ml

0.28

Other epidermal thickening

124

3.52

12.81

1.3

1.1

—

38.60

—

Bacterial intestinal infections, IBD co-morbidities

134

676

2.00

12.69

1.3

1.2

59.00

73.19

u/ml

—

Other disorders of bone

142

731

1.96

12.69

1.3

1.2

76.87

56.52

u/ml

—

Other retinal disorders

422

2174

1.48

12.66

1.2

84.79

78.13

u/ml

0.14

Atrial fibrillation and flutter

196

706

1.80

12.52

1.2

92.17

93.06

u/ml

—

Diseases of the digestive system

303

1924

1.57

12.45

1.3

1.2

86.83

76.21

u/ml

0.17

Other external causes of accidental injury

508

1770

1.44

12.37

1.2

72.43

67.20

u/ml

0.12

Conjunctivitis

518

2957

1.41

12.35

1.3

1.2

54.18

71.37

u/ml

0.87

102

Hard cardiovascular diseases

547

2295

1.41

12.29

1.2

62.04

76.71

u/ml

0.55

Anti-inflammatory and antirheumatic products, non-steroids

129

308

2.11

12.28

1.2

38.43

60.80

u/ml

—

Fissure and fistula of anal and rectal regions

163

888

1.85

12.26

1.3

1.2

76.00

65.94

u/ml

—

Injuries to the ankle and foot

485

2913

1.43

12.22

1.3

1.2

60.47

66.49

u/ml

0.15

110

Other and unspecified effects of external causes

191

1092

1.76

12.22

1.3

1.2

64.25

70.30

u/ml

—

Purpura and other haemorrhagic conditions

102

472

2.18

12.18

1.3

1.2

75.33

67.13

u/ml

—

Other cataract

281

1306

1.61

12.18

1.2

80.27

88.76

u/ml

0.12

Phlebitis and thrombophlebitis (not including DVT)

164

898

1.84

12.15

1.3

1.2

90.67

61.84

u/ml

—

Primary gonarthrosis, bilateral

346

1912

1.52

12.06

1.2

82.25

77.88

u/ml

—

Other diseases of urinary system

638

2615

1.37

12.03

1.2

79.52

67.88

u/ml

0.37

Disorders of other endocrine glands

296

1869

1.56

12.03

1.3

1.2

58.27

74.93

u/ml

0.40

Lichen ruber planus, wide definition including periferal and oral lichen planus

172

959

1.81

12.03

1.2

71.00

81.79

u/ml

—

Asthma/COPD (KELA code 203)

622

3041

1.37

11.95

1.2

91.80

65.93

u/ml

—

123

Heart failure and bmi 25plus

251

1019

1.65

11.90

1.2

79.10

78.36

u/ml

—

DVT of lower extremities

132

679

1.96

11.86

1.2

32.80

70.77

u/ml

—

DVT of lower extremities and pulmonary embolism

276

1747

1.58

11.72

1.2

76.23

82.80

u/ml

0.11

Accidents

503

1770

1.43

11.65

1.2

72.61

67.20

u/ml

0.12

Other bacterial intestinal infections

130

670

1.95

11.62

1.3

1.2

59.00

77.11

u/ml

—

Conduction disorders

192

885

1.75

11.60

1.3

1.2

98.57

79.64

u/ml

—

Hernia

608

2960

1.37

11.60

1.2

64.78

69.71

u/ml

0.11

116

Venous thromboembolism

355

2299

1.49

11.56

1.3

1.2

64.31

77.35

u/ml

0.28

Varicose veins

412

2140

1.46

11.55

1.3

1.2

84.32

72.63

u/ml

0.25

Nephropathy related operations

393

2.26

11.50

1.3

1.2

99.60

83.60

u/ml

—

Intestinal infectious diseases

616

3377

1.36

11.49

1.3

1.2

55.14

71.58

u/ml

0.62

120

All influenza

165

921

1.80

11.48

1.2

55.60

68.10

u/ml

—

Non-selective monoamine reuptake inhibitors

251

1503

1.61

11.47

1.2

71.33

75.01

u/ml

0.06

Deforming dorsopathies

184

1063

1.74

11.37

1.4

1.2

117.38

66.21

u/ml

—

Exposure to unspecified factor

667

3384

1.34

11.37

1.2

71.88

68.21

u/ml

0.10

113

Thyroiditis, ILD-related definition

376

2.28

11.37

1.3

1.2

39.00

33.75

u/ml

—

Bleeding

522

2631

1.39

11.30

1.2

60.95

76.96

u/ml

0.49

Other diseases of blood and blood-forming organs, wide

155

854

1.83

11.30

1.3

1.2

57.77

71.50

u/ml

0.34

Diseases of middle ear and mastoid

373

2070

1.48

11.27

1.2

80.31

59.15

u/ml

0.54

Diseases of pulp and periapical tissues and dental caries

389

1347

1.48

11.14

1.2

74.67

67.91

u/ml

0.14

Erysipelas

343

1984

1.49

11.13

1.2

76.20

83.33

u/ml

0.15

Implicit fungal Sepsis, including avohilmo

240

2.62

11.12

1.3

1.1

65.17

48.33

u/ml

—

Viral infections characterized by skin and mucous membrane lesions

279

1802

1.55

11.05

1.3

1.2

56.07

78.46

u/ml

0.80

Acute bronchitis

267

1676

1.57

11.01

1.3

1.2

66.89

81.35

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

451

2855

1.41

10.99

1.3

1.2

55.40

70.41

u/ml

0.43

109

Falls/tendency to fall

681

2546

1.34

10.97

1.2

65.03

68.43

u/ml

0.09

Dentofacial anomalies [including malocclusion]

478

2674

1.40

10.90

1.3

1.2

69.09

64.73

u/ml

0.12

103

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

656

3150

1.34

10.83

1.3

1.2

64.95

70.89

u/ml

0.16

116

Dipeptidyl peptidase 4 (DPP-4) inhibitors

364

1948

1.47

10.73

1.1

1.2

89.82

87.10

u/ml

0.06

Ankylosing spondylitis, ICD10

280

2.45

10.73

1.3

1.2

—

70.22

—

Other acute lower respiratory infections

336

2162

1.48

10.71

1.3

1.2

75.45

79.13

u/ml

0.05

Cerebrovascular diseases (FINNGEN)

192

794

1.70

10.40

1.2

65.33

73.04

u/ml

—

Paracetamol or NSAID medication

143

2.55

10.40

1.2

1.3

44.67

59.57

u/ml

—

Dental caries, including avohilmo

432

1546

1.43

10.39

1.2

72.79

66.24

u/ml

0.15

Injury, poisoning and certain other consequences of external causes

334

1113

1.51

10.31

1.2

60.33

62.29

u/ml

—

Chondropathies

108

548

1.99

10.18

1.2

95.83

50.19

u/ml

—

Alzheimer disease

977

0.42

10.14

1.2

84.20

79.63

u/ml

—

Other gastritis (incl. Duodenitis)

136

746

1.83

10.10

1.3

1.2

15.50

76.13

u/ml

—

Postpartum haemorrhage due to anatomy

383

2.19

10.08

1.3

52.17

66.23

u/ml

—

Isolated proteinuria

4.02

10.08

1.1

1.2

—

43.20

—

Degenerative diseases of the nervous system

1120

0.46

10.06

1.2

70.50

80.07

u/ml

—

Keratitis

236

1503

1.58

10.05

1.2

77.07

71.70

u/ml

0.11

Fall on same level

731

2987

1.31

9.95

1.2

77.86

62.75

u/ml

0.59

Other bacterial intestinal infections, including avohilmo

160

926

1.74

9.93

1.3

1.2

68.55

65.81

u/ml

0.04

Later onset COPD, excluding more controls

119

472

1.93

9.91

1.2

63.33

80.71

u/ml

—

Transport accidents

293

1625

1.50

9.86

1.3

1.2

54.17

66.85

u/ml

0.33

Benign neoplasms

595

2417

1.34

9.80

1.2

84.65

64.66

u/ml

0.59

Other diseases of intestine

106

542

1.97

9.78

1.3

1.2

76.20

60.65

u/ml

—

Other and unspecified coagulation defects

159

2.87

9.66

1.3

1.2

69.40

38.43

u/ml

—

Irregular menses

343

1775

1.46

9.63

1.3

29.33

68.11

u/ml

3.04

Nontoxic single thyroid nodule

246

2.47

9.61

1.3

1.2

72.50

61.73

u/ml

—

Injuries to the neck

151

869

1.75

9.57

1.2

11.17

76.00

u/ml

—

Other inflammation of eyelid, including avohilmo

296

2001

1.48

9.57

1.3

1.2

67.00

69.93

u/ml

0.05

Contact with and exposure to communicable diseases

1231

0.42

9.49

1.3

27.71

61.98

u/ml

—

Lichen planus

100

509

1.98

9.39

1.2

75.80

72.33

u/ml

—

Suppurative and unspecified otitis media

217

1216

1.59

9.35

1.2

1.3

63.30

60.82

u/ml

—

Any dementia

1225

0.51

9.34

1.1

1.2

77.63

78.70

u/ml

—

Lichen planus, including avohilmo

139

788

1.78

9.32

1.2

63.33

73.24

u/ml

—

Synovial cyst of popliteal space [Baker]

214

2.55

9.29

1.2

—

50.00

—

Selective serotonin reuptake inhibitors

610

2395

1.33

9.24

1.2

79.91

68.74

u/ml

0.29

External causes of morbidity and mortality

392

1380

1.43

9.21

1.2

63.86

66.48

u/ml

0.04

Abnormal findings on examination of urine, without diagnosis

121

3.10

9.11

1.1

—

43.20

—

Other disorders of fluid, electrolyte and acid-base balance

217

1305

1.57

9.11

1.2

77.06

79.71

u/ml

0.06

Other diseases of the respiratory system

128

713

1.81

9.10

1.3

1.2

111.29

66.00

u/ml

—

Other respiratory disorders and diseases

128

713

1.81

9.10

1.3

1.2

111.29

66.00

u/ml

—

139

741

1.76

8.98

1.2

96.20

71.90

u/ml

—

Substance abuse, excluding more controls

340

1990

1.43

8.92

1.3

1.2

60.46

63.58

u/ml

0.05

Viral hepatitis, IBD co-morbidity

4.21

8.91

1.3

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

243

1581

1.52

8.90

1.2

63.09

59.86

u/ml

0.06

Tonsillectomy and adenotomy

343

1667

1.44

8.88

1.3

48.80

61.76

u/ml

—

Nonsuppurative otitis media, including avohilmo

192

1033

1.61

8.87

1.2

115.67

62.67

u/ml

—

Nonsuppurative otitis media

136

670

1.77

8.85

1.3

1.2

102.14

49.04

u/ml

—

IgA nephropathy (IgA glomerulonephritis)

4.08

8.83

1.2

1.1

—

43.20

—

Other viral diseases, including avohilmo

234

1518

1.53

8.82

1.3

1.2

67.83

62.45

u/ml

—

Endocrine, nutritional and metabolic diseases

463

1704

1.37

8.81

1.2

62.82

71.20

u/ml

0.23

Use of pramipexole

149

876

1.71

8.81

1.3

1.2

80.40

71.24

u/ml

—

Hypo-osmolality and hyponatraemia

128

716

1.78

8.75

1.3

1.2

73.00

70.63

u/ml

0.04

Intracranial injury

363

2414

1.40

8.71

1.2

91.43

67.95

u/ml

0.80

Acute suppurative otitis media

156

866

1.69

8.67

1.2

1.3

66.25

46.07

u/ml

—

Trochanteric bursitis

100

524

1.92

8.65

1.4

1.2

97.33

79.27

u/ml

—

Ménière disease

335

2.17

8.64

1.3

1.2

112.00

73.55

u/ml

—

Excessive earwax

400

2635

1.38

8.57

1.3

1.2

80.00

74.95

u/ml

0.08

Zoster [herpes zoster], including avohilmo

340

2328

1.41

8.51

1.3

1.2

69.93

80.03

u/ml

0.34

Cystitis

536

2403

1.33

8.49

1.3

1.2

74.43

66.04

u/ml

0.26

Other inflammation of eyelid

101

535

1.90

8.47

1.3

1.2

108.33

72.13

u/ml

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

185

1162

1.60

8.45

1.2

22.83

73.48

u/ml

—

Major coronary heart disease event

516

2318

1.33

8.41

1.2

62.50

77.20

u/ml

0.53

Oral lichen planus, including avohilmo , including avohilmo

256

2.33

8.39

1.3

1.2

66.20

64.17

u/ml

—

Coxarthrosis, primary

376

2251

1.39

8.38

1.2

60.40

82.71

u/ml

—

Inflammatory diseases of the central nervous system

275

2.28

8.37

1.4

1.2

97.67

47.09

u/ml

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

198

1268

1.57

8.33

1.3

1.2

76.56

68.60

u/ml

—

Injuries to the thorax

279

1922

1.46

8.23

1.2

69.08

73.87

u/ml

0.07

Conjunctivitis (acute, non atopic)

180

1129

1.59

8.13

1.2

62.23

73.23

u/ml

0.25

Persons with potential health hazards related to communicable diseases

1563

0.52

8.12

1.4

1.2

53.75

62.76

u/ml

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

149

898

1.67

8.07

1.2

72.29

76.77

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

628

3037

1.29

8.05

1.2

86.08

67.84

u/ml

0.62

111

Benign paroxysmal vertigo

201

1303

1.55

8.04

1.2

64.44

81.04

u/ml

—

Ischemic heart diseases

511

2297

1.33

8.04

1.2

62.29

77.63

u/ml

0.55

Type of accident

182

1154

1.58

8.02

1.3

1.2

76.56

69.15

u/ml

—

Substance abuse

340

2264

1.40

8.00

1.3

1.2

60.46

71.61

u/ml

0.22

Fracture at wrist and hand level

205

1333

1.54

7.95

1.3

1.2

67.56

70.75

u/ml

—

Pulmonary heart disease, diseases of pulmonary circulation

196

1268

1.55

7.90

1.3

1.2

90.25

76.31

u/ml

0.25

Emergency coronary revascularization (for ACS)

517

2368

1.32

7.90

1.3

1.2

59.85

77.91

u/ml

0.76

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

328

2.12

7.88

1.4

1.2

95.33

43.10

u/ml

—

COPD

266

1483

1.46

7.82

1.2

84.75

83.57

u/ml

—

Car occupant injured in other and unspecified transport accidents

118

674

1.76

7.78

1.3

1.2

52.17

76.79

u/ml

—

Other coagulation defects

260

2.25

7.67

1.3

1.2

69.40

49.75

u/ml

—

Other CVD

122

710

1.73

7.54

1.2

65.40

76.79

u/ml

—

Covid-19 confirmed case

231

1563

1.48

7.51

1.3

1.2

68.64

77.40

u/ml

0.15

Viral pneumonia

430

1.94

7.49

1.3

1.2

56.00

69.38

u/ml

—

Postmenopausal atrophic vaginitis

169

569

1.63

7.47

1.3

1.2

61.11

92.17

u/ml

—

Gingivitis and periodontal diseases

611

2459

1.29

7.46

1.2

51.48

75.99

u/ml

1.10

Disorders of vitreous body

329

2262

1.39

7.44

1.2

75.75

78.01

u/ml

0.05

Chondromalacia

3.31

7.42

1.3

1.1

—

43.20

—

Any mental disorder

677

2677

1.27

7.40

1.2

86.58

66.48

u/ml

0.77

Peripheral arterial reconstruction

546

1.82

7.37

1.2

67.80

82.20

u/ml

—

Percutaneous Coronary Intervention

478

2206

1.32

7.34

1.3

1.2

61.96

79.33

u/ml

0.63

Cholelithiasis

540

2851

1.29

7.34

1.2

93.00

66.88

u/ml

0.93

110

Colonic or urogenital fistula

169

1080

1.57

7.25

1.3

1.2

93.57

61.48

u/ml

—

Any dementia, excluding more controls

1112

0.55

7.23

1.1

1.2

77.63

75.46

u/ml

—

Coronary revascularization (ANGIO or CABG)

478

2209

1.32

7.22

1.2

61.96

79.33

u/ml

0.63

Disorders of vitreous body and globe

333

2293

1.38

7.21

1.2

72.76

76.80

u/ml

0.09

Dislocation, sprain and strain of joints and ligaments of knee

379

2545

1.35

7.18

1.2

1.3

66.69

68.98

u/ml

0.04

Injuries to the head

694

3285

1.25

7.17

1.2

87.43

63.16

u/ml

1.28

110

Alzheimer disease, including avohilmo

1118

0.55

7.16

1.2

84.20

76.62

u/ml

—

Fibroblastic disorders

127

759

1.68

7.15

1.2

105.80

65.68

u/ml

—

Disorders of parathyroid gland

136

818

1.65

7.14

1.3

1.2

52.50

73.83

u/ml

—

Degeneration of macula and posterior pole

294

1615

1.41

7.09

1.2

86.27

83.97

u/ml

0.04

Childhood asthma (age<16), excluding more controls

206

2.21

7.06

1.2

—

27.14

—

Other keratitis

398

1.95

7.03

1.2

104.20

65.58

u/ml

—

Cholelithiasis, broad definition with cholecystitis

556

2890

1.28

7.02

1.2

93.00

66.88

u/ml

0.93

110

Dysplasia of cervi uteri

155

679

1.61

7.01

1.3

57.43

76.34

u/ml

—

Bitten or struck by other mammals

427

1.91

6.98

1.4

1.2

61.83

58.73

u/ml

—

181

1014

1.54

6.96

1.2

98.67

76.49

u/ml

—

Mental and behavioural disorders due to psychoactive substance use

343

2316

1.36

6.86

1.3

1.2

60.46

72.64

u/ml

0.24

Inflammatory diseases of prostate (prostatitis)

348

1.99

6.77

1.1

1.2

—

116.50

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

245

1691

1.43

6.74

1.2

69.00

77.22

u/ml

0.17

Trigger finger

475

1.84

6.73

1.2

—

67.50

—

Erosion of teeth , including avohilmo

167

1084

1.55

6.73

1.3

1.2

84.62

65.27

u/ml

—

Unspecific neurodegenerative disorder

114

1293

0.60

6.72

1.1

1.2

93.50

79.15

u/ml

—

Other viral diseases

169

1097

1.54

6.69

1.3

1.2

67.83

68.09

u/ml

—

Other disorders of breast

104

601

1.74

6.67

1.3

1.2

51.40

59.61

u/ml

—

Disorders of continuity of bone

357

1.98

6.67

1.2

—

49.83

—

Other chronic obstructive pulmonary disease

251

1442

1.43

6.64

1.2

71.25

83.06

u/ml

—

Iridocyclitis

137

852

1.62

6.64

1.2

75.14

77.87

u/ml

—

Childhood asthma (age<16)

212

2.14

6.61

1.2

—

27.14

—

Ganglion

117

702

1.67

6.53

1.3

1.2

58.40

59.86

u/ml

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

351

2512

1.34

6.49

1.3

1.2

54.43

68.90

u/ml

0.57

Diabetes mellitus

629

2901

1.25

6.48

1.2

1.3

54.90

73.23

u/ml

0.63

109

Hypertensive heart and/or renal disease

161

758

1.56

6.39

1.2

79.71

87.52

u/ml

—

Symptoms and signs involving speech and voice

215

1488

1.45

6.36

1.3

1.2

99.91

78.20

u/ml

0.44

Ovarian cyst

204

785

1.49

6.35

1.2

1.3

50.92

82.54

u/ml

0.98

Disorders of breast

340

2233

1.34

6.31

1.3

84.33

64.26

u/ml

0.55

105

Hypertensive diseases

477

2084

1.29

6.30

1.2

1.3

75.18

68.32

u/ml

0.17

Allergic conjunctivitis

367

2670

1.33

6.28

1.3

1.2

54.43

67.25

u/ml

0.50

104

Hypertension

476

2081

1.29

6.25

1.2

1.3

75.18

68.32

u/ml

0.17

Diabetes, varying definitions

624

2901

1.25

6.23

1.2

1.3

54.90

73.23

u/ml

0.63

109

Familial hypercholesterolemia, with ischemic heart disease

311

2.01

6.22

1.2

—

109.86

—

Type 2 diabetes

609

2823

1.25

6.16

1.2

1.3

56.47

73.90

u/ml

0.55

108

Glucosamine medication

287

1669

1.38

6.14

1.3

1.2

77.22

82.23

u/ml

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

157

1014

1.53

6.13

1.3

1.2

23.40

52.93

u/ml

—

Explicit bacterial Sepsis

348

1.94

6.08

1.3

1.2

50.80

65.80

u/ml

—

Urinary track infection

392

1486

1.32

6.04

1.3

62.45

66.92

u/ml

0.12

Explicit bacterial Sepsis, including avohilmo

357

1.92

5.99

1.3

1.2

50.80

65.80

u/ml

—

Fracture of rib(s), sternum and thoracic spine

176

1187

1.49

5.97

1.2

74.60

72.90

u/ml

—

Any death

226

2217

0.71

5.95

1.2

55.57

84.47

u/ml

0.95

Anterior Iridocyclitis

124

777

1.60

5.89

1.2

73.60

72.76

u/ml

—

Injuries to the shoulder and upper arm

516

3162

1.26

5.88

1.2

67.78

70.34

u/ml

0.05

119

Tinnitus

147

959

1.54

5.86

1.3

1.2

85.80

70.91

u/ml

—

Peripheral artery disease

241

1358

1.41

5.86

1.3

1.2

102.00

80.32

u/ml

0.36

Other follicular disorders

237

2.13

5.85

1.3

1.2

—

31.43

—

Ocular pain

307

1.97

5.73

1.4

1.2

84.80

51.00

u/ml

—

Abnormal findings on diagnostic imaging of central nervous system

156

2.40

5.72

1.4

1.2

—

30.40

—

Desensitization to allergens

156

2.39

5.72

1.1

1.2

—

34.38

—

Excessive attrition of teeth

380

2900

1.30

5.71

1.2

48.73

69.24

u/ml

0.60

112

HSIL lesion of the cervix uteri, vagina or vulva

133

854

1.56

5.71

1.3

70.67

56.31

u/ml

0.28

Endometriosis of rectovaginal septum and vagina

260

2.05

5.69

1.4

1.2

57.20

104.00

u/ml

—

Other peripheral vertigo

336

1.92

5.67

1.2

93.80

69.18

u/ml

—

Atherosclerosis, excluding cerebral and coronary sclerosis

226

1263

1.41

5.60

1.2

98.55

79.64

u/ml

0.32

Injuries to the elbow and forearm

433

2913

1.28

5.57

1.3

1.2

97.86

66.91

u/ml

0.83

119

Noninflammatory disorders of female genital tract

228

805

1.43

5.55

1.3

49.33

82.54

u/ml

0.90

Psychiatric diseases

584

2356

1.24

5.53

1.2

83.20

66.84

u/ml

0.50

Other chronic obstructive pulmonary disease, including avohilmo

312

1926

1.33

5.52

1.2

64.00

85.26

u/ml

—

Thyrotoxicosis, other and/or unspecified

125

798

1.57

5.51

1.2

75.60

75.50

u/ml

—

Abnormal findings on diagnostic imaging of other body structures

507

1.73

5.49

1.5

1.2

51.60

74.05

u/ml

—

Myelodysplastic syndrome, including Hilmo

2.85

5.43

1.2

—

82.50

—

Panniculitis, unspecified

5.76

5.42

1.1

1.2

—

Hypertension, essential

461

2054

1.27

5.39

1.2

87.50

68.61

u/ml

0.57

Inflammatory disease of uterus

563

1.68

5.38

1.5

1.3

39.30

72.15

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

563

2697

1.24

5.38

1.2

1.3

78.82

73.38

u/ml

0.11

106

Maternal care for other known or suspected fetal problems

151

625

1.52

5.33

1.3

11.20

50.44

u/ml

—

Fracture of foot, except ankle

147

981

1.50

5.31

1.3

1.2

81.00

71.44

u/ml

—

Endometriosis

193

778

1.45

5.26

1.3

50.75

82.54

u/ml

—

Neoplasms

416

1701

1.28

5.26

1.2

57.36

65.88

u/ml

0.19

Coxarthrosis, primary, with hip surgery

275

1904

1.34

5.22

1.2

67.50

88.22

u/ml

—

Corneal ulcer

107

668

1.61

5.21

1.2

80.00

77.36

u/ml

—

Pneumoconiosis due to asbestos and other mineral fibres

4.64

5.19

1.3

1.1

—

265

0.23

5.19

1.2

—

99.14

—

Type 2 diabetes, wide definition

461

2308

1.26

5.19

1.2

81.07

76.49

u/ml

0.10

Fracture of lumbar spine and pelvis

129

840

1.54

5.18

1.2

62.25

77.77

u/ml

—

Other Crohn's disease

216

2.10

5.15

1.2

—

34.56

—

Radial styloid tenosynovitis [de Quervain]

164

2.27

5.14

1.1

1.2

—

65.80

—

Use of anticholinesterases

1131

0.61

5.12

1.1

1.2

84.40

78.28

u/ml

—

N06DA Anticholinesterases

1131

0.61

5.12

1.1

1.2

84.40

78.28

u/ml

—

Female genital prolapse

171

647

1.47

5.11

1.3

64.78

84.33

u/ml

—

Other noninflammatory disorders of uterus, except cervix

126

542

1.56

5.03

1.3

1.2

37.71

90.00

u/ml

—

AV-block

520

1.63

5.01

1.2

1.1

—

70.11

—

STROKE

319

1637

1.31

5.01

1.2

91.36

73.95

u/ml

0.35

Behçet disease

12.18

4.86

1.1

—

Type 2 diabetes, definitions combined

574

2734

1.22

4.86

1.2

1.3

55.78

73.38

u/ml

0.53

106

Superficial injury of shoulder and upper arm

421

1.74

4.84

1.3

1.2

57.20

58.69

u/ml

—

Asthma and opportunity respiratory infection

156

2.27

4.83

1.2

1.1

—

59.88

—

Other and unspecified disorders of vitreous body

264

1942

1.33

4.83

1.1

1.2

85.50

80.19

u/ml

0.11

Schizophrenia, schizotypal and delusional disorders

1262

0.60

4.78

1.3

1.2

59.00

64.43

u/ml

—

Dermatophytosis, including avohilmo

383

2970

1.27

4.76

1.3

1.2

106.83

62.46

u/ml

1.06

103

Injuries to the hip and thigh

279

1899

1.32

4.74

1.2

66.00

80.24

u/ml

0.32

Codes for special purposes

313

2398

1.30

4.72

1.3

1.2

75.84

70.76

u/ml

0.11

Viral warts

344

1.81

4.69

1.3

1.2

28.40

48.17

u/ml

—

Deficiency of other B group vitamins

3.06

4.69

1.2

—

43.20

—

COPD, hospital admissions

250

1575

1.34

4.68

1.2

71.25

85.00

u/ml

—

Other specified/unspecified bacterial intestinal infections

218

2.03

4.67

1.4

1.1

45.20

50.13

u/ml

—

Nonorganic sleeping disorders, excluding more controls

117

767

1.53

4.65

1.3

1.2

44.83

59.67

u/ml

—

Type 2 diabetes, strict (exclude DM1)

575

2753

1.22

4.65

1.2

1.3

55.78

73.38

u/ml

0.53

106

Provisional assignment of new diseases of uncertain etiology

312

2397

1.29

4.63

1.3

1.2

66.94

71.79

u/ml

0.11

Other noninflammatory disorders of vulva and perineum

353

1.80

4.62

1.1

1.3

35.00

82.44

u/ml

—

Sleep disorders

547

3097

1.22

4.59

1.3

1.2

56.86

70.98

u/ml

0.53

115

Anogenital herpesviral [herpes simplex] infection, including avohilmo

391

1.75

4.57

1.4

1.3

48.20

53.17

u/ml

—

Episcleritis

160

2.21

4.56

1.4

1.2

—

46.40

—

Complications predominantly related to the puerperium

168

1189

1.42

4.55

1.3

87.14

66.56

u/ml

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

312

1.84

4.52

1.4

1.2

—

52.00

—

Cholecystectomy

435

2981

1.24

4.51

1.2

90.38

68.87

u/ml

0.61

117

COPD related to multimorbidity

219

1366

1.36

4.50

1.2

70.43

77.21

u/ml

—

Other erythematous conditions

2.55

4.47

1.4

1.1

—

43.20

—

239

1612

1.34

4.46

1.2

47.11

87.13

u/ml

—

Type 2 diabetes, definitions combined, including avohilmo

572

2732

1.21

4.46

1.2

1.3

53.47

73.96

u/ml

0.68

105

Behavioural syndromes associated with physiological disturbances and physical factors

561

3137

1.21

4.46

1.3

1.2

62.30

70.38

u/ml

0.24

116

Other diseases of the digestive system

171

1219

1.41

4.44

1.2

35.20

72.78

u/ml

—

Deep endometriosis

380

1.75

4.44

1.4

1.2

57.20

57.95

u/ml

—

Other benign neoplasms of skin

221

1643

1.35

4.44

1.3

1.2

62.00

80.56

u/ml

—

COPD, early/later onset

251

1590

1.33

4.44

1.2

71.25

83.06

u/ml

—

Postmenopausal bleeding

154

553

1.46

4.43

1.3

1.2

79.60

90.00

u/ml

—

Non-invasive ventilation

126

731

1.49

4.38

1.2

78.50

81.18

u/ml

—

Seronegative juvenile rheumatoid arthritis

3.25

4.35

1.2

—

38.43

—

Sequelae of injuries, of poisoning and of other consequences of external causes

135

926

1.46

4.35

1.2

84.00

64.61

u/ml

—

Diabetic retinopathy, strict definition

528

1.59

4.33

1.2

—

55.24

—

Heart failure and coronary heart disease

236

1237

1.34

4.31

1.2

67.70

85.47

u/ml

—

Pulmonary embolism

164

1168

1.41

4.30

1.3

1.2

89.40

72.37

u/ml

—

Volume depletion

311

1.81

4.26

1.2

—

78.13

—

Benign thyroid growths and nodules

197

1345

1.36

4.25

1.3

1.2

86.92

79.72

u/ml

0.14

Congenital malformations, deformations and chromosomal abnormalities

337

2529

1.26

4.22

1.3

1.2

50.00

68.30

u/ml

0.62

Diabetes medication

625

3060

1.19

4.20

1.2

1.3

54.21

72.39

u/ml

0.62

114

Use of hypnotics and sedatives

633

3039

1.19

4.15

1.3

1.2

73.92

68.78

u/ml

0.13

107

Other and unspecified erythematous conditions

2.55

4.14

1.4

1.1

—

43.20

—

Pulmonary heart disease

164

1177

1.40

4.13

1.3

1.2

89.40

72.37

u/ml

—

Contraceptive management

232

1220

1.33

4.12

1.3

1.2

72.50

67.39

u/ml

0.09

Liquid cancers

176

1209

1.38

4.12

1.2

66.77

91.61

u/ml

0.56

Viral warts, including avohilmo

120

817

1.47

4.04

1.3

1.2

31.75

76.53

u/ml

—

Epilepsy

152

1078

1.41

4.03

1.3

1.2

74.89

70.89

u/ml

—

Other disorders of eyelid

253

1835

1.30

4.03

1.2

54.50

84.44

u/ml

—

Zoster [herpes zoster]

110

737

1.50

4.02

1.3

1.2

53.00

80.33

u/ml

—

Necrosis of pulp, including avohilmo

347

2746

1.25

3.99

1.3

1.2

71.55

68.30

u/ml

0.08

Diabetes, insulin treatment (Kela reimbursement)

589

2941

1.19

3.96

1.2

1.3

69.00

68.68

u/ml

0.01

119

Diabetic maculopathy, excluding more controls

341

1.74

3.95

1.2

—

67.46

—

Hypertensive Heart Disease

135

711

1.44

3.95

1.2

69.88

91.13

u/ml

—

Injury of muscle and tendon at shoulder and upper arm level

199

1486

1.34

3.94

1.2

85.50

76.77

u/ml

—

Disorders of male genital organs in diseases classified elsewhere

7.46

3.89

1.5

1.0

—

Hypoparathyroidism

119

2.29

3.88

1.3

1.2

49.20

53.71

u/ml

—

Liquid cancers, including Hilmo

212

1409

1.33

3.87

1.2

70.00

93.15

u/ml

0.61

Ankylosing spondylitis, strict definition

126

2.24

3.84

1.2

—

43.20

—

Contact with machinery

315

1.75

3.82

1.2

1.1

—

86.78

—

Exclusions for E4_PCOS_CONSORTIUM

436

2230

1.22

3.81

1.3

77.47

65.67

u/ml

0.28

Primary coxarthrosis, bilateral

161

1170

1.38

3.81

1.3

1.2

56.17

87.98

u/ml

—

Insulin medication

332

2203

1.25

3.80

1.2

112.67

80.08

u/ml

—

Septal defects

156

2.08

3.79

1.2

—

33.88

—

conjunctival haemorrhage

265

1.82

3.77

1.2

1.1

—

61.50

—

Other and unspecified tonsillitis

161

970

1.38

3.76

1.3

1.2

93.29

63.74

u/ml

—

Other disorders of eye and adnexa

540

1.56

3.74

1.4

1.2

64.29

72.19

u/ml

—

Impetigo

134

2.18

3.74

1.3

1.2

—

40.67

—

Female infertility

165

715

1.39

3.73

1.3

87.60

75.24

u/ml

—

Paralytic ileus and intestinal obstruction

130

915

1.42

3.69

1.2

51.33

76.97

u/ml

—

Postpartum hemorraghe, all women as controls

153

1081

1.38

3.69

1.3

45.00

56.13

u/ml

—

Hernia of abdominal wall

252

1965

1.29

3.68

1.1

1.2

89.70

79.71

u/ml

—

MS-disease / Multiple Sclerosis

253

1.83

3.67

1.3

1.2

—

40.40

—

Spontaneous abortion

293

1549

1.27

3.66

1.2

1.3

34.64

65.49

u/ml

1.21

Insulin, combination of fast acting with intermediate-acting or long-acting

332

2425

1.24

3.63

1.2

112.67

78.57

u/ml

—

Pustulosis palmaris et plantaris

136

2.15

3.62

1.3

1.1

—

51.25

—

Voice disturbances

161

1182

1.37

3.60

1.3

1.2

117.63

71.64

u/ml

—

All dysplastic lesions of the cervix uteri, vagina or vulva

182

1329

1.34

3.57

1.3

65.69

57.85

u/ml

0.15

Persistent mood disorders

109

750

1.46

3.54

1.2

61.14

69.82

u/ml

—

Other (not insulin) diabetes medications

584

2906

1.18

3.53

1.2

58.10

72.51

u/ml

0.46

111

COPD, hospital admission 2, with asthma infections

167

1063

1.36

3.50

1.2

81.17

71.33

u/ml

—

Appendectomy

375

2928

1.22

3.48

1.3

1.2

91.79

65.11

u/ml

0.68

116

Fall on and from stairs and steps

151

1104

1.37

3.48

1.3

1.2

45.40

64.56

u/ml

—

Other and unspecified drugs and medicaments

310

1.72

3.46

1.4

1.2

—

47.23

—

Medical abortion

395

1751

1.22

3.45

1.3

65.67

70.25

u/ml

0.08

Open wound of head

290

2176

1.25

3.45

1.2

87.55

74.90

u/ml

0.36

Superficial injury of lower leg

146

1065

1.37

3.42

1.2

70.60

68.17

u/ml

—

Dementia

151

1398

0.74

3.39

1.1

1.2

84.56

80.86

u/ml

—

Personality disorders, excluding more controls

129

921

1.40

3.39

1.3

1.2

39.14

61.23

u/ml

—

Vitamin B12 deficiency anaemia

327

1.69

3.38

1.3

1.2

—

68.67

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

138

854

1.39

3.37

1.2

81.17

75.25

u/ml

—

Lung cancer and mesothelioma

475

1.52

3.35

1.2

47.78

79.64

u/ml

—

Agranulocytosis

405

1.61

3.35

1.3

1.2

79.14

55.87

u/ml

—

Vulvovaginal ulceration/inflammation in other diseases

261

1.77

3.34

1.4

1.2

87.71

54.20

u/ml

—

COPD, hospital admissions 1, only main diagnosis

178

1151

1.33

3.34

1.2

79.67

71.14

u/ml

—

Thyrotoxicosis

151

1113

1.36

3.33

1.2

75.60

74.27

u/ml

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

369

2766

1.22

3.33

1.3

53.06

70.04

u/ml

0.60

106

Other strabismus

116

816

1.42

3.30

1.2

65.00

70.19

u/ml

—

Retinal detachments and breaks

193

1477

1.31

3.30

1.2

85.00

87.82

u/ml

—

Malignant neoplasm of pancreas

241

0.33

3.29

1.0

1.1

—

78.25

—

Myocardial infarction, without ST-elevation

206

1433

1.30

3.28

1.2

91.11

77.23

u/ml

—

Strabismus

141

1028

1.37

3.27

1.2

65.00

68.98

u/ml

—

Other specified and unspecified disorders of lens

4.84

3.26

1.1

1.2

—

Amenorrhoea

213

1.84

3.22

1.5

1.3

—

85.00

—

GI-bleeding

162

1215

1.34

3.19

1.2

34.67

72.78

u/ml

—

Actinic keratosis

208

1469

1.29

3.16

1.2

40.00

90.63

u/ml

—

Nonorganic sleeping disorders

117

835

1.41

3.16

1.3

1.2

44.83

70.46

u/ml

—

Postpartum haemorrhage

153

938

1.35

3.14

1.3

45.00

64.18

u/ml

—

Metabolic disorders

551

2821

1.17

3.14

1.2

79.17

64.91

u/ml

0.45

103

Extrapyramidal and movement disorders

218

1708

1.28

3.13

1.2

78.00

84.99

u/ml

—

Organic, including symptomatic, mental disorders

187

1706

0.77

3.13

1.2

88.54

77.71

u/ml

0.27

Skin changes due to chronic exposure to nonionizing radiation

215

1520

1.28

3.12

1.2

42.38

87.13

u/ml

—

Polycystic ovarian syndrome

201

1.85

3.12

1.4

1.3

—

41.70

—

Fracture of lower leg, including ankle

305

2438

1.23

3.11

1.2

54.44

72.39

u/ml

—

In situ neoplasms

231

1825

1.27

3.11

1.3

1.2

76.75

79.54

u/ml

0.05

Pustular psoriasis

152

1.99

3.10

1.3

1.1

—

56.14

—

Other disorders of kidney and ureter

453

1.55

3.10

1.2

—

79.14

—

Postpartum hemorraghe, parous women as controls

153

954

1.34

3.09

1.3

45.00

62.92

u/ml

—

Dementia, including avohilmo

164

1471

0.76

3.05

1.2

82.38

81.98

u/ml

—

Severe visual impairment, binocular

5.99

3.04

1.4

1.3

—

Other condition

512

1.51

3.02

1.3

1.2

69.60

51.27

u/ml

—

Blepharochalasis

164

1245

1.32

3.01

1.2

64.40

81.94

u/ml

—

Other diseases of pancreas

293

1.68

3.00

1.2

—

50.56

—

Insomnia

519

3086

1.17

2.99

1.3

1.2

57.19

71.74

u/ml

0.55

116

Primary_lymphoid and hematopoietic malignant neoplasms

126

920

1.37

2.99

1.3

1.2

86.89

69.15

u/ml

—

Acidosis

2.66

2.97

1.1

—

Salpingitis and oophoritis

106

753

1.41

2.97

1.2

1.3

54.00

82.45

u/ml

—

Other neurological diseases

406

2643

1.19

2.95

1.3

1.2

78.69

72.69

u/ml

0.14

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

641

0.57

2.92

1.2

—

75.32

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

157

1190

1.32

2.92

1.3

23.40

66.40

u/ml

—

Pre-eclampsia or poor fetal growth

183

1411

1.29

2.91

1.3

64.40

61.00

u/ml

—

Convulsions, not elsewhere classified

101

705

1.42

2.90

1.2

52.50

69.47

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

560

0.55

2.86

1.2

—

72.82

—

Cardiac murmurs and other cardiac sounds

256

1.71

2.85

1.2

1.3

—

42.00

—

Crushed, pushed or stepped on by crowd or human stampede

200

1.81

2.85

1.4

1.2

—

34.38

—

Benign neoplasm: Rectum

701

1.42

2.84

1.4

1.2

54.60

81.75

u/ml

—

Congenital malformations of cardiac septa

173

1.86

2.82

1.3

1.2

—

38.43

—

Golimumab

103

2.15

2.81

1.1

1.2

—

43.20

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.01

2.80

1.1

—

Atypical facial pain

166

1.88

2.76

1.3

1.2

—

53.67

—

Optic neuritis

138

1.97

2.75

1.1

1.2

—

42.29

—

Umbilical hernia

138

1039

1.33

2.72

1.2

92.83

78.73

u/ml

—

Certolizumab pegol

2.62

2.71

1.1

1.2

—

44.67

—

Cerebrovascular diseases

405

2375

1.18

2.70

1.2

67.12

80.60

u/ml

0.36

Acne

279

1.64

2.64

1.5

1.3

—

39.64

—

Neuromuscular dysfunction of bladder

304

1.62

2.64

1.3

1.2

—

51.10

—

Recurrent dislocation of patella

113

2.05

2.61

1.1

1.2

—

35.80

—

Other and unspecified acne

3.09

2.57

1.5

1.1

—

Malignant neoplasm of pancreas, including Hilmo

288

0.41

2.54

1.0

1.2

—

98.90

—

HSIL lesion of the cervix uteri

106

780

1.36

2.47

1.2

1.3

82.88

56.67

u/ml

—

Multifocal fibrosclerosis

5.10

2.41

1.0

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

465

1.47

2.40

1.3

1.2

87.13

72.81

u/ml

—

Exposure to other specified electric current

0.00

2.39

0.0

1.2

—

43.20

—

Pregnancy with abortive outcome

396

1757

1.18

2.38

1.2

1.3

50.53

70.25

u/ml

0.52

Cervicobrachial syndrome

112

837

1.34

2.37

1.2

56.60

52.13

u/ml

—

Post-traumatic stress disorder

274

1.61

2.37

1.3

—

40.08

—

Dental pulpitis, including avohilmo

525

2934

1.15

2.36

1.2

82.37

64.42

u/ml

0.59

106

Benign neoplasm: Rectum, anus and anal canal

108

804

1.35

2.35

1.4

1.2

62.33

76.40

u/ml

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

190

1530

1.24

2.28

1.3

1.2

51.54

77.60

u/ml

0.69

Vascular dementia

278

0.45

2.28

1.0

1.2

—

64.00

—

Retinal breaks without detachment

630

1.39

2.27

1.1

1.2

79.17

73.76

u/ml

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

172

0.35

2.26

1.2

—

87.00

—

Dislocation of lens

3.92

2.25

1.1

1.0

—

Schizoaffective disorder

259

0.42

2.25

1.5

1.2

—

34.56

—

Myocardial infarction

253

1461

1.21

2.25

1.2

79.33

90.69

u/ml

0.23

Pure hyperglyceridaemia

2.35

2.22

1.2

1.1

—

Sequelae of cerebrovascular disease

185

1270

1.25

2.22

1.2

65.78

81.62

u/ml

—

Fracture of forearm

308

2343

1.18

2.18

1.3

1.2

102.70

68.70

u/ml

—

101

Bell's palsy

393

1.48

2.18

1.3

1.2

72.00

49.20

u/ml

—

Obsessive-compulsive disorder

188

1.71

2.16

1.3

—

21.78

—

Duodenal ulcer

282

1.57

2.13

1.3

1.1

—

124.00

—

Atrial septal defect

2.02

2.12

1.4

1.2

—

42.67

—

Bipolar affective disorders

698

1.35

2.12

1.3

—

70.92

—

Superficial injury of hip and thigh

546

1.40

2.09

1.1

1.2

50.67

63.11

u/ml

—

Infectious mononucleosis

252

1.59

2.09

1.3

—

47.40

—

Infectious mononucleosis, including avohilmo

252

1.59

2.09

1.3

—

47.40

—

Diabetic maculopathy

375

1.47

2.06

1.2

—

63.08

—

Nonspecific lymphadenitis

191

1.68

2.06

1.4

1.2

—

43.38

—

Total colectomy operation

117

1.89

2.06

1.5

1.1

—

43.20

—

Total colectomy

117

1.89

2.06

1.5

1.1

—

43.20

—

Nontoxic goitre/thyroid nodule

168

1353

1.24

2.06

1.3

1.2

86.92

77.03

u/ml

0.21

Benign neoplasm of breast

490

1.41

2.05

1.2

52.67

68.88

u/ml

—

Use of biperiden

160

0.37

2.02

1.3

1.1

—

43.40

—

Hypogonadotropic hypogonadism

2.24

2.01

1.4

1.1

—

Persons encountering health services for specific procedures, not carried out

300

0.50

2.01

1.2

—

53.29

—

Outcome of delivery

424

0.66

2.01

1.2

1.3

—

49.70

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

139

1085

1.27

2.01

1.3

60.29

61.43

u/ml

—

Abnormal spermatozoa

376

1.47

2.00

1.2

—

86.71

—

Mouth breathing

197

1619

1.22

1.97

1.2

81.80

79.02

u/ml

—

Benign neoplasm of urinary organs

156

1.74

1.96

1.3

1.1

—

56.14

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

4.66

1.95

1.6

1.1

—

Other dermatomyositis

4.64

1.95

1.8

1.2

—

Other diseases of arteries and capillaries

298

1.52

1.92

1.5

1.2

—

50.00

—

Benign lipomatous neoplasm

154

1241

1.24

1.90

1.3

1.2

91.88

67.00

u/ml

—

Effects of foreign body entering through natural orifice

113

878

1.29

1.89

1.3

1.2

105.40

66.69

u/ml

—

Calcific tendinitis

3.22

1.89

1.1

1.2

—

Other fall from one level to another

105

810

1.30

1.85

1.3

1.2

47.80

67.96

u/ml

—

Non-follicular lymphoma

309

1.49

1.85

1.3

1.1

75.50

56.00

u/ml

—

LSIL lesion of the cervix uteri, vagina or vulva

603

1.35

1.84

1.3

69.40

65.52

u/ml

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

272

2010

1.17

1.84

1.3

71.44

58.54

u/ml

—

Diastasis of muscle

3.57

1.84

1.5

1.2

—

Effects of air pressure and water pressure

4.24

1.83

1.2

—

Aortic aneurysm

103

779

1.30

1.82

1.1

1.2

62.40

81.38

u/ml

—

Major coronary heart disease event excluding revascularizations

307

1740

1.17

1.82

1.3

1.2

72.36

88.49

u/ml

0.40

Emotional disorders starting during childhood or adolecense, excluding more controls

2.02

1.81

1.1

1.4

—

27.67

—

Open wound of hip and thigh

2.01

1.80

1.1

1.2

—

45.60

—

Severe visual impairment, monocular

2.79

1.80

1.3

1.2

—

Atopic conjunctivitis

146

1.72

1.78

1.3

1.2

—

34.67

—

Ulcerative proctitis

192

1.62

1.77

1.5

1.2

—

42.67

—

Calcific aortic valvular stenosis, including rheumatic fever

140

1084

1.24

1.75

1.4

1.2

71.63

79.29

u/ml

—

All dysplastic lesions of the cervix uteri

145

1155

1.24

1.75

1.3

74.33

56.63

u/ml

—

Sequelae of external causes of morbidity and mortality

132

1058

1.25

1.74

1.2

72.00

69.46

u/ml

—

Extreme obesity with alveolar hypoventilation

132

1.75

1.74

1.3

1.1

—

36.33

—

Narcolepsy and cataplexy

3.90

1.72

1.4

1.1

—

Intentional self-harm by hanging, strangulation and suffocation

3.90

1.72

1.0

1.2

—

Calcific aortic valvular stenosis

139

1080

1.24

1.71

1.4

1.2

71.63

79.29

u/ml

—

Calcific aortic valvular stenosis, operated

139

1080

1.24

1.71

1.4

1.2

71.62

79.29

u/ml

—

Calcific aortic valvular stenosis, diagnosis (helper)

139

1080

1.24

1.71

1.4

1.2

71.63

79.29

u/ml

—

Operations 2 for CAVS

139

1080

1.24

1.71

1.4

1.2

71.63

79.29

u/ml

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

254

2153

1.17

1.70

1.3

1.2

86.08

64.70

u/ml

0.59

Haemorrhage in early pregnancy

161

1284

1.22

1.70

1.3

43.50

61.62

u/ml

—

Other ulcerative colitis

187

1.61

1.69

1.2

—

33.00

—

Other specified/unspecified hearing loss

280

0.53

1.67

1.3

1.1

—

75.40

—

Disorders of porphyrin and bilirubin metabolism

2.61

1.66

1.1

—

Abnormalities of gait and mobility

434

1.39

1.66

1.2

71.86

75.11

u/ml

—

Burns and corrosions

443

1.38

1.65

1.3

1.2

—

64.00

—

Nontoxic diffuse goitre

112

1.80

1.65

1.2

1.1

—

46.86

—

Campylobacter enteritis

2.04

1.65

1.1

—

43.20

—

Disorders of phosphorus metabolism and phosphatases

3.64

1.62

1.0

—

Other abnormal auditory perceptions

2.53

1.60

1.3

1.2

—

Other secondary coxarthrosis

106

1.80

1.59

1.2

1.1

—

36.33

—

Acute appendicitis, no complications

292

2525

1.15

1.58

1.3

1.2

81.67

67.31

u/ml

0.28

Other disorders of the musculoskeletal system and connective tissue

550

1.33

1.58

1.2

—

79.57

—

Benign neoplasm of eye and adnexa

389

1.39

1.55

1.2

—

58.86

—

Postprocedural musculoskeletal disorders, not elsewhere classified

257

1.48

1.53

1.3

1.1

—

56.00

—

Leiomyoma of uterus

372

1842

1.13

1.52

1.3

80.56

65.58

u/ml

0.41

Sequelae of other and unspecified infectious and parasitic diseases

169

1.60

1.52

1.4

1.2

—

42.67

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

169

1.60

1.52

1.4

1.2

—

42.67

—

Other hearing loss

132

1043

1.23

1.51

1.3

1.2

42.60

82.46

u/ml

—

Intestinal stricture

152

1259

1.21

1.51

1.2

103.00

73.33

u/ml

—

Benign neoplasm: Stomach

349

1.41

1.51

1.4

1.2

—

65.46

—

Female infertility, cervical, vaginal, other or unspecified origin

135

704

1.23

1.48

1.3

95.63

75.24

u/ml

—

Antepartum haemorrhage, not elsewhere classified

309

1.43

1.47

1.5

1.3

—

54.17

—

Ischaemic heart disease, wide definition

406

2229

1.12

1.43

1.3

1.2

60.22

83.68

u/ml

0.79

Diseases of appendix

401

3206

1.12

1.42

1.3

1.2

84.29

67.11

u/ml

0.42

114

Ulcerative rectosigmoiditis

279

1.44

1.40

1.2

—

34.56

—

Procreative management

160

1104

1.19

1.40

1.3

1.2

39.14

55.92

u/ml

—

Burn and corrosion of wrist and hand

1.78

1.39

1.4

1.1

—

43.20

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

194

1.52

1.38

1.5

1.2

—

35.71

—

Pure hypercholesterolaemia

409

2326

1.12

1.37

1.2

78.53

70.00

u/ml

0.18

Fall on same level involving ice and snow

314

2780

1.13

1.35

1.3

1.2

60.93

72.50

u/ml

0.23

109

Contusion of ankle

112

1.70

1.35

1.3

1.2

—

40.67

—

Coronary atherosclerosis

330

1843

1.13

1.35

1.2

50.91

89.76

u/ml

1.17

Personality disorders

129

1067

1.21

1.34

1.3

1.2

39.14

67.12

u/ml

—

Complications following abortion and ectopic and molar pregnancy

128

1.65

1.33

1.2

—

72.50

—

Biguanides

530

2909

1.10

1.33

1.2

54.53

72.06

u/ml

0.59

109

Appendicitis, broad definition

396

3191

1.11

1.33

1.3

1.2

82.85

67.66

u/ml

0.33

113

Polypectomy (DHB20)

208

0.53

1.33

1.4

1.1

—

36.33

—

Gilbert syndrome

2.53

1.31

1.2

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

339

2346

1.12

1.30

1.3

1.2

74.69

63.25

u/ml

0.21

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.77

1.29

1.4

1.2

—

40.67

—

Cerebral cysts

185

1.52

1.29

1.1

1.2

—

13.67

—

Burns and corrosions of external body surface, specified by site

352

1.37

1.28

1.4

1.2

—

55.42

—

Other disorders of male genital organs

1.89

1.28

1.2

1.1

—

Congenital malformations of heart and great arteries

383

1.35

1.28

1.2

—

57.93

—

Acute appendicitis

370

3081

1.11

1.28

1.3

1.2

82.85

66.87

u/ml

0.36

110

Nontoxic multinodular goitre

758

1.24

1.26

1.3

1.2

109.50

84.30

u/ml

—

Acne vulgaris

210

1.48

1.26

1.5

1.3

—

43.75

—

Other bursal cyst

2.24

1.24

1.1

1.2

—

Primary open-angle glaucoma

154

1256

1.18

1.24

1.1

1.2

78.13

85.87

u/ml

—

Delirium, not induced by alcohol and other psychoactive substances

433

0.69

1.24

1.3

1.1

103.40

74.70

u/ml

—

Charcot foot

2.01

1.23

1.1

1.2

—

Synovial hypertrophy, not elsewhere classified

2.65

1.22

1.2

—

Other noninfective disorders of lymphatic vessels and lymph nodes

116

1.65

1.21

1.3

1.1

—

38.60

—

Later onset COPD

128

858

1.20

1.2

54.43

77.16

u/ml

—

Sequelae of injuries of lower limb

324

0.65

1.20

1.2

56.20

39.78

u/ml

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.33

1.19

1.0

1.2

—

Sequelae of infectious and parasitic diseases

222

1.45

1.18

1.3

1.2

—

33.25

—

Caught, crushed, jammed or pinched in or between objects

165

1.52

1.17

1.3

1.2

—

38.43

—

Emotional disorders and disorders of social functioning with onset specific to childhood

107

1.65

1.17

1.1

1.3

—

30.67

—

Need for other prophylactic measures

186

0.54

1.17

1.3

1.1

—

50.13

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

211

0.57

1.16

1.4

1.2

—

96.63

—

Congenital malformations of eye, ear, face and neck

190

1.48

1.16

1.1

1.2

—

34.38

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.51

1.15

1.0

—

Insulin, fast-acting (human)

474

1.29

1.13

1.3

1.2

—

44.58

—

Pregnancy hypertension

236

1862

1.13

1.12

1.2

1.3

67.25

62.02

u/ml

—

Gestational diabetes (for exclusion)

152

1218

0.86

1.09

1.3

22.43

58.76

u/ml

—

Blindness, monocular

2.40

1.09

1.2

—

Endometriosis ASRM stages 3,4

125

1056

1.19

1.09

1.3

1.2

49.17

65.63

u/ml

—

Anorexia

1.96

1.09

1.5

1.1

—

43.20

—

Abnormal blood-pressure reading, without diagnosis

129

1.56

1.05

1.2

—

52.43

—

Other symptoms and signs involving cognitive functions and awareness

234

1839

1.13

1.05

1.2

45.57

89.70

u/ml

—

Disorders of iron metabolism

1.97

1.04

1.1

—

Sequelae of infectious and parasitic diseases, including avohilmo

229

1.40

1.03

1.3

1.2

—

33.25

—

Care involving use of rehabilitation procedures

262

2629

0.89

1.03

1.2

44.67

67.69

u/ml

—

Hidradenitis suppurativa

114

1.59

1.02

1.3

—

36.33

—

Atrial septal defect, secundum type

1.74

1.02

1.4

1.2

—

51.00

—

Endovascular or surgical operations to intracerebral aneurysms

202

0.59

1.01

1.0

1.2

—

53.14

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

1.90

1.01

1.2

—

43.20

—

Mental disorders, not otherwise specified

275

0.65

1.01

1.1

1.2

—

34.56

—

Disorders of adult personality and behaviour

131

1121

1.17

1.00

1.3

39.14

67.12

u/ml

—

Other specified/unspecified disorders of bone/cartilage

1.72

0.99

1.3

1.1

—

43.20

—

Other congenital malformations of circulatory system

1.68

0.98

1.4

1.1

—

43.20

—

Cervicocranial syndrome

379

1.30

0.98

1.2

—

50.33

—

Primary open-angle glaucoma, strict

123

1048

1.17

0.97

1.1

1.2

74.60

81.44

u/ml

—

Motor neuron disease ALS

1.81

0.97

1.0

1.2

—

Motor neuron disease (with DMD)

1.81

0.97

1.0

1.2

—

Unspecified privation

371

1.30

0.96

1.2

—

61.23

—

Hypertrophic scar

166

1.45

0.94

1.1

1.2

—

35.14

—

Postprocedural disorders of digestive system, not elsewhere classified

1.62

0.94

1.4

1.1

—

43.20

—

Other bursitis of knee

2.23

0.93

1.2

1.3

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

142

0.56

0.93

1.4

1.1

—

36.33

—

Malignant neoplasm of kidney, except renal pelvis

295

1.33

0.92

1.1

1.2

—

98.90

—

Other viral hepatitis, including avohilmo

192

1.41

0.92

1.4

1.2

—

42.67

—

Malignant neoplasm of urinary organs

322

1.31

0.91

1.0

1.2

—

95.27

—

Examination and encounter for administrative purposes

176

1.42

0.90

1.1

1.2

—

68.57

—

Other viral hepatitis

168

1.43

0.89

1.3

1.2

—

43.20

—

Non-allergic asthma

265

0.68

0.88

1.3

1.1

—

46.18

—

Parkinson's disease

538

0.78

0.86

1.1

1.2

—

86.53

—

Hydronephrosis

387

1.27

0.86

1.1

1.2

92.40

65.55

u/ml

—

Contact with other sharp object(s)

204

1.38

0.85

1.1

1.2

—

35.00

—

Other obstetric trauma

187

1.39

0.85

1.4

1.3

—

61.13

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

167

0.60

0.85

1.5

1.1

—

87.00

—

Benign neoplasm: Liver

1.63

0.85

1.4

1.2

—

43.20

—

Hodgkin lymphoma, hilmo

1.63

0.84

1.2

1.1

—

43.20

—

Contact with other hot fluids

1.63

0.84

1.5

1.1

—

43.20

—

Malignant neoplasm of corpus uteri, including Hilmo

400

0.75

0.83

1.1

1.2

—

76.65

—

Primary angle-closure glaucoma

139

0.57

0.83

1.4

1.1

—

72.67

—

Foreign body in alimentary tract

163

1.42

0.82

1.4

1.2

—

33.88

—

Calcaneal spur

1.88

0.82

1.3

1.2

—

Amyloidosis

1.65

0.82

1.2

1.1

—

Glaucoma

288

2232

1.10

0.81

1.2

79.33

83.17

u/ml

0.09

Maternal care for other conditions predominantly related to pregnancy

106

888

1.16

0.81

1.3

93.40

62.79

u/ml

—

Benign neoplasm: Choroid

232

1.34

0.81

1.2

1.1

—

56.00

—

Other embolism and thrombosis

445

1.24

0.80

1.2

42.50

82.78

u/ml

—

Cyst of kidney

250

1.32

0.80

1.1

—

56.00

—

Squamous cell neoplasms and carcinomas of the skin

338

1.27

0.79

1.1

—

85.73

—

Parkinson's disease, including avohilmo

564

0.80

0.79

1.1

1.2

—

82.06

—

Placenta praevia

147

0.61

0.79

1.3

—

58.09

—

Male infertility

1.59

0.78

1.1

—

Dissection of cerebral arteries, nonruptured

0.00

0.78

0.0

1.2

—

Clear cell adenocarcinoma of kidney

165

1.40

0.77

1.1

—

87.00

—

Other degenerative diseases of the nervous system

117

740

1.15

0.77

1.2

54.67

99.06

u/ml

—

Specific personality disorders

104

898

1.16

0.77

1.2

1.3

44.50

67.44

u/ml

—

Convergent concomitant strabismus

174

1.38

0.76

1.5

1.2

—

35.00

—

Malignant neoplasm of breast, HER2-negative

203

1452

0.90

0.76

1.3

76.10

74.19

u/ml

—

Burn and corrosion confined to eye and adnexa

1.70

0.76

1.1

—

43.20

—

Malignant neoplasm of corpus uteri

359

0.75

1.1

1.2

—

82.89

—

Foreign body in respiratory tract

149

1.41

0.75

1.1

1.2

—

33.00

—

Malignant neoplasm of breast

203

1451

0.90

0.75

1.3

76.10

74.19

u/ml

—

Hereditary corneal dystrophies

124

1.46

0.75

1.3

1.2

—

68.29

—

Type 1 diabetes, strict definition, subgroup 1

184

0.65

0.74

1.5

1.2

—

47.17

—

Emotional disorders starting during childhood or adolescence

107

1.48

0.73

1.1

1.3

—

17.00

—

Malignant neoplasm of bladder, including Hilmo

383

1.24

0.72

1.2

—

98.67

—

Adjustment and management of implanted device

622

0.82

0.72

1.3

1.2

—

74.59

—

Maternal care for known or suspected disproportion

134

1.42

0.71

1.3

—

39.80

—

Pedal cyclist injured in collision with motor vehicle

101

1.49

0.70

1.2

—

44.67

—

Focal epilepsy

776

1.16

0.69

1.4

1.2

58.86

73.35

u/ml

—

Benign neoplasm: Liver/bile ducts

1.54

0.69

1.4

1.2

—

43.20

—

Vestibular neuronitis

310

1.26

0.69

1.1

1.2

—

65.88

—

LSIL lesion of the vulva

110

1.46

0.68

1.4

1.2

—

42.67

—

Decubitus ulcer and pressure area

187

1.34

0.68

1.1

—

40.00

—

Preterm labour and delivery

130

1153

1.13

0.68

1.2

55.40

68.22

u/ml

—

Ischaemic Stroke, excluding all haemorrhages

273

1849

1.09

0.67

1.2

69.40

82.66

u/ml

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.64

0.67

1.1

—

43.20

—

Transient global amnesia

339

1.24

0.66

1.2

42.80

71.00

u/ml

—

Melanocytic naevi of other and unspecified parts of face

202

0.69

0.65

1.2

—

58.70

—

Exposure to other and unspecified inanimate mechanical forces

251

1.28

0.64

1.3

1.2

—

36.86

—

Mumps

1.53

0.62

1.2

—

43.20

—

Disorders of psychological development

283

1.25

0.62

1.2

1.3

—

47.18

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

121

1.41

0.62

1.1

—

36.33

—

Persistent delusional disorders

245

0.73

0.61

1.2

—

56.00

—

Other complications of labour and delivery, not elsewhere classified

415

0.81

0.61

1.2

1.3

—

45.62

—

Malignant neoplasm of mesothelium and soft tissue

139

0.65

0.60

1.1

—

90.57

—

Cyst of Bartholin Gland

139

1.37

0.60

1.3

1.2

—

38.83

—

Malignant neoplasm of eye, brain and central nervous system

140

0.64

0.60

1.3

1.1

—

38.60

—

Malignant neoplasm, including Hilmo

465

2552

1.06

0.60

1.2

1.3

57.83

72.47

u/ml

0.62

Chronic lymphocytic leukaemia

105

1.43

0.60

1.2

1.1

—

59.00

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

105

1.43

0.60

1.2

1.1

—

59.00

—

Chronic lymphocytic leukaemia, helper endpoint

105

1.43

0.60

1.2

1.1

—

59.00

—

Burns and corrosions confined to eye and internal organs

1.53

0.59

1.1

—

43.20

—

Disorders of lipoprotein metabolism and other lipidaemias

431

2467

1.06

0.58

1.2

74.56

69.91

u/ml

0.10

Sequelae with surgical and medical care as external cause

818

1.14

0.58

1.2

87.50

72.68

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

104

922

1.13

0.58

1.2

93.29

64.42

u/ml

—

Medicines for HER+ breast cancer

165

1687

0.91

0.58

1.2

103.00

66.37

u/ml

—

Mumps, including avohilmo

1.49

0.57

1.2

—

43.20

—

Other obstructive and reflux uropathy

124

1.37

0.55

1.4

1.2

—

24.20

—

Disorders of refraction and accommodation

129

1158

1.11

0.55

1.4

1.2

95.00

68.57

u/ml

—

Use of selegiline

148

0.67

0.55

1.2

1.1

—

59.00

—

Anorexia (incl.atypical)

177

1.30

0.54

1.2

1.3

—

36.25

—

Stroke, including SAH

307

2060

1.07

0.54

1.2

73.50

82.42

u/ml

0.16

Malignant neoplasm of brain, including Hilmo

159

0.69

0.54

1.4

1.1

—

67.29

—

Other osteochondropathies

231

1.26

0.53

1.1

1.2

—

34.56

—

Other and unspecified disease of Bartholin gland

108

1.39

0.53

1.3

1.2

—

67.29

—

Malignant neoplasm, wide definition

464

2558

1.06

0.53

1.2

1.3

57.83

72.47

u/ml

0.62

Periapical abscess

225

2087

1.08

0.53

1.2

84.75

68.85

u/ml

—

Other congenital malformations of skin

117

1.37

0.52

1.5

1.1

—

33.00

—

Benign neoplasm: Kidney

117

1.37

0.52

1.3

1.1

—

56.14

—

Benign neoplasm: Vulva

1.45

0.52

1.1

—

36.33

—

Any event in cancer register

492

2729

1.05

0.51

1.2

1.3

71.43

68.74

u/ml

0.07

Paralytic strabismus

233

1.25

0.51

1.2

1.1

—

56.00

—

Benign neoplasm: Skin of scalp and neck

1.47

0.50

1.3

1.1

—

43.20

—

Complications of labour and delivery

342

1787

1.06

0.50

1.3

53.17

69.03

u/ml

0.56

Type 1 diabetes, strict definition

201

0.74

0.49

1.4

1.2

—

47.17

—

Other specified and unspecified disorders of eye and adnexa

108

0.65

0.48

1.1

—

43.20

—

Other specified disorders of kidney and ureter

1.40

0.48

1.2

1.1

—

44.60

—

Other and unspecified injuries of head

244

1.23

0.48

1.1

1.2

—

41.00

—

Viral hepatitis, including avohilmo

235

1.24

0.48

1.4

1.2

—

42.67

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

162

1743

0.92

0.48

1.2

81.50

72.60

u/ml

—

Use of levodopa decarboxylase inhibitor

485

0.84

0.47

1.1

—

79.38

—

Malignant neoplasm of bronchus and lung

647

0.88

0.47

1.2

53.50

86.91

u/ml

—

Parkinson's disease, strict definition

495

0.85

0.47

1.1

1.2

—

87.93

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

278

1922

1.06

0.46

1.3

74.69

59.99

u/ml

0.28

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

232

0.77

0.46

1.1

—

87.78

—

Tuberculosis

165

1.27

0.45

1.2

1.1

—

37.50

—

Stroke, excluding SAH

288

1959

1.06

0.43

1.2

78.64

81.73

u/ml

0.05

Focal epilepsy, strict definition

705

1.12

0.43

1.4

1.2

57.67

68.68

u/ml

—

Other obstetric conditions, not elsewhere classified

156

907

1.09

0.43

1.4

1.3

26.17

50.92

u/ml

—

L02BG Aromatase inhibitors

136

1460

0.92

0.43

1.2

91.29

72.47

u/ml

—

Crossbite

161

1.26

0.43

1.4

1.2

—

30.78

—

Secondary uncertain malignant neoplasm

480

1.15

0.42

1.2

78.20

76.93

u/ml

—

Sleep disorders, other/unspecified

113

1.33

0.42

1.1

1.2

—

36.25

—

Malignant neoplasm of respiratory system and intrathoracic organs

723

0.89

0.42

1.2

79.44

83.33

u/ml

—

Normotensive glaucoma

317

0.82

0.42

1.0

1.1

—

83.08

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

612

1.13

0.42

1.2

99.60

72.45

u/ml

—

Overexertion and strenuous or repetitive movements

349

0.83

0.42

1.3

1.2

—

65.25

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.41

0.0

1.1

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.41

0.0

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

661

1.12

0.41

1.4

1.2

66.00

79.35

u/ml

—

Dilated cardiomyopathy

380

0.84

0.40

1.1

—

83.92

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

150

873

1.08

0.40

1.4

1.3

30.80

49.03

u/ml

—

Maltreatment syndromes

159

1.26

0.40

1.2

—

38.63

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.31

0.39

1.0

1.2

—

45.60

—

Viral hepatitis

214

1.22

0.39

1.3

1.2

—

43.20

—

Pedestrian injured in transport accident

237

0.80

0.39

1.1

1.2

—

31.00

—

Non-Hodgkin lymphoma, all

142

1.27

0.38

1.2

1.1

—

78.33

—

Viral infections of the central nervous system

233

1.20

0.38

1.1

1.2

—

54.90

—

Ingrowing nail

151

1.26

0.38

1.3

1.2

—

57.00

—

Malignant neoplasm of breast, including Hilmo

216

1471

0.94

0.38

1.3

69.73

73.69

u/ml

0.07

Malignant neoplasm of breast, HER2-negative, including Hilmo

216

1471

0.94

0.38

1.3

69.73

73.69

u/ml

0.07

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.39

0.38

1.0

1.1

—

Alcohol use disorder, ICD-based

150

1612

0.93

0.38

1.2

64.14

73.62

u/ml

—

Viral infections of the central nervous system, including avohilmo

252

1.19

0.37

1.1

1.2

—

54.90

—

Speech and linguistic disorders, excluding more controls

176

1.23

0.37

1.2

1.3

—

23.86

—

Malignant neoplasm of stomach

169

0.77

0.37

1.1

—

101.17

—

Malignant neoplasm of breast, ER-positive, including Hilmo

159

1265

0.93

0.35

1.2

103.00

75.66

u/ml

—

Motorcycle rider injured in noncollision transport accidents

0.64

0.35

1.2

—

53.40

—

Myocardial infarction, strict

204

1359

1.06

0.35

1.2

79.33

89.61

u/ml

0.20

Contact with heat and hot substances

153

1.24

0.35

1.4

1.2

—

38.43

—

Basal cell carcinoma

205

1482

0.94

0.35

1.2

61.29

90.84

u/ml

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

208

1.20

0.35

1.2

—

33.88

—

Fracture of femur

108

897

1.09

0.34

1.3

1.2

63.00

73.10

u/ml

—

Malignant neoplasm of breast, HER-positive

159

1264

0.94

0.34

1.2

103.00

75.66

u/ml

—

Persons encountering health services in circumstances related to reproduction

262

1668

1.05

0.34

1.3

1.2

57.71

66.38

u/ml

0.16

Brachial plexus disorders

321

1.15

0.33

1.3

—

61.82

—

Other acquired deformities of musculoskeletal system and connective tissue

137

1.24

0.32

1.1

—

36.33

—

Other abnormal findings of blood chemistry

153

0.78

0.30

1.2

1.1

—

36.33

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

828

0.92

0.30

1.3

1.2

68.67

92.54

u/ml

0.51

Malignant neoplasm of stomach, including Hilmo

196

0.82

0.30

1.1

—

87.00

—

473

0.89

0.30

1.3

1.2

—

67.61

—

Other inflammation of vagina/vulva

141

0.78

0.29

1.5

1.2

—

45.17

—

Carcinoma in situ of skin of other and unspecified parts of face

297

1.15

0.29

1.2

—

86.78

—

Other disorders starting during childhood or adolescence

106

0.75

0.29

1.3

—

39.14

—

Other disorders of breast and lactation associated with childbirth

1.23

0.29

1.7

1.3

—

51.00

—

Angina pectoris

241

1674

0.95

0.28

1.3

1.2

58.44

88.63

u/ml

—

Benign neoplasm: Skin, unspecified

121

1.24

0.28

1.4

1.1

—

43.20

—

Asthma mixed form (mode), excluding more controls

121

1.24

0.28

1.3

1.2

—

66.80

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

140

0.78

0.28

1.2

1.1

—

76.50

—

Prolapse and hernia of ovary and fallopian tube

1.28

0.28

1.3

1.2

—

62.13

—

malignant neoplasm of male genital organs, including Hilmo

109

610

1.07

0.27

1.1

1.2

—

102.30

—

Perineal laceration during delivery

557

1.09

0.27

1.3

33.00

53.90

u/ml

—

Amyloidosis, other/unspecified

1.23

0.27

1.3

1.1

—

Asthma mixed form (mode)

122

1.23

0.27

1.3

1.2

—

66.80

—

Melanocytic naevi

127

1348

0.94

0.26

1.3

1.2

72.00

65.37

u/ml

—

Respiratory tuberculosis, confirmed and not-confirmed

141

1.21

0.26

1.3

1.2

—

37.50

—

Respiratory tuberculosis

141

1.21

0.26

1.3

1.2

—

37.50

—

Hemiplegia

141

1.21

0.26

1.3

1.1

—

36.86

—

Cardiomyopathy, other and unspecified

235

0.85

0.25

1.2

1.1

—

78.50

—

236

2196

0.96

0.25

1.2

66.67

73.44

u/ml

0.11

Diabetes mellitus in pregnancy

143

960

0.95

0.25

1.3

10.33

58.36

u/ml

—

Malignant neoplasm of bronchus and lung, including Hilmo

733

0.93

0.23

1.2

47.78

90.00

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

254

0.87

0.23

1.2

—

36.33

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS